MATERNAL ANXIETY DURING PREGNANCY: ITS RELATIONS TO BIRTH OUTCOMES AND TO OFFSPRING DEPRESSION DURING LATE CHILDHOOD AND ADOLESCENCE by Hosseini, Shahla Marie
 Doctor of Philosophy 
 
 
 
 
 
 
 
University of Pittsburgh 
 
2006 
of the requirements for the degree of 
Graduate School of Public Health in partial fulfillment  
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
B. S., Biochemistry, University of Maryland Baltimore County, 1999 
Shahla Marie Hosseini 
 
 
 
 
 
 
 
 
 
by 
MATERNAL ANXIETY DURING PREGNANCY:  ITS RELATIONS TO BIRTH 
OUTCOMES AND TO OFFSPRING DEPRESSION DURING LATE CHILDHOOD AND 
ADOLESCENCE 
UNIVERSITY OF PITTSBURGH 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
This dissertation was presented 
by 
 
Shahla Marie Hosseini 
 
It was defended on August 4, 2006 
and approved by 
 
Nancy L. Day, PhD 
Dissertation Advisor and Committee Chair, Professor 
Departments of Psychiatry and Epidemiology 
School of Medicine and Graduate School of Public Health 
University of Pittsburgh 
 
Cynthia Larkby, PhD 
Committee Member, Assistant Professor 
Departments of Psychiatry and Epidemiology 
School of Medicine and Graduate School of Public Health 
University of Pittsburgh  
 
Minhnoi Wroble Biglan, PhD 
Committee Member, Assistant Professor 
Department of Psychology 
School of Liberal Arts 
Pennsylvania State University 
 
Maria Mori Brooks, PhD 
Committee Member, Assistant Professor 
Department of Epidemiology 
Graduate School of Public Health 
University of Pittsburgh 
 
Michael B. Gorin, MD, PhD 
Committee Member, Professor 
Department of Ophthalmology and Human Genetics 
School of Medicine and Graduate School of Public Health 
University of Pittsburgh 
  ii
Copyright © by Shahla Marie Hosseini 
2006 
  iii
MATERNAL ANXIETY DURING PREGNANCY:  ITS RELATIONS TO 
BIRTH OUTCOMES AND TO OFFSPRING DEPRESSION DURING LATE 
CHILDHOOD AND ADOLESCENCE 
 
Shahla Marie Hosseini, PhD 
University of Pittsburgh, 2006
Nancy L. Day, Ph.D. 
 
There has been renewed interest in recent years in the short- and long-term effects of 
prenatal maternal anxiety (PMA) on offspring.  Although relations between PMA and adverse 
birth outcomes have been established previously, the nature of these relations is not well-
characterized.  Furthermore, it is unknown whether the effects of PMA last into late childhood 
and adolescence to increase the offspring’s risk of depression.  The goals of this dissertation 
were:  1) Characterize the relations between PMA and birth outcomes; 2) Determine the 
correlates of Major Depressive Disorder (MDD) among offspring; 3) Determine whether PMA 
predicts depressive symptoms in offspring at 10 to 16 years.   
Women (n=829) of low socioeconomic status, recruited from a prenatal clinic, were 
assessed for trait anxiety (PMA) during their fourth and seventh gestational months, and at 
delivery, in a study of prenatal substance use.  There were 763 live singleton births.  At 10, 14, 
and 16 years post-partum, trait anxiety and depressive symptoms were measured in women and 
their offspring.  Offspring were assessed at 16 years for MDD.  Demographic, social, substance 
use, medical, psychological, and psychiatric status were controlled.   
It was demonstrated in the first paper that PMA predicted lower birth weight, shorter 
birth length, and shorter gestational length, controlling for confounders.  Women who reported 
chronic, severe trait anxiety were at the highest risk of having shorter gestations and delivering 
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smaller babies.  The second paper established that female gender, a history of childhood 
maltreatment, and a maternal history of MDD independently increased the odds of MDD in the 
16-year-olds.  Daughters of women with a history of MDD were particularly vulnerable.  The 
third paper found that PMA was related to level of depressive symptoms in late childhood and 
adolescence.  These effects were significant, controlling for current maternal depression.  Female 
gender and lower maternal education also predicted depressive symptoms in children ages 10-16 
years.  There was a significant interaction between gender and follow-up assessment. 
These findings have public health implications:  maternal psychological health during 
pregnancy and throughout the child’s development should be monitored in order to improve birth 
outcomes and psychological health of children and adolescents. 
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1.0  INTRODUCTION/OVERVIEW 
Little is known about the long-term effects on the psychological and psychiatric health of 
offspring exposed to prenatal maternal anxiety (PMA).  It is conceivable that modifications of 
fetal brain development occur in the wombs of anxious women such that long-term effects are 
observed on the psychological and psychiatric profiles of the offspring.   
 Some of the existing human studies of PMA are limited in that key covariates have not 
been measured, follow-up times of the offspring tend to be short, and primarily behavioral and 
emotional symptoms (rather than either psychiatric diagnosis or symptoms of depression) in the 
offspring have been obtained.  Thus, this proposal to study the effects of PMA is original in that I 
propose to explore longitudinal depressive symptoms and a specific psychiatric diagnosis, major 
depressive disorder (MDD), as outcomes in the offspring.  The goal of this dissertation is to 
explore the hypothesis that, in our cohort of mothers and their children, prenatal maternal trait 
anxiety impacts fetal and child development, such that the adolescents are more prone to MDD, 
and they have more depressive symptoms in late childhood and adolescence.  Thus, in achieving 
this goal, the specific aims of this research are to:  
1. Identify covariates of prenatal maternal anxiety. 
2. Determine adverse birth outcomes predicted by prenatal maternal anxiety. 
3. Identify significant covariates of major depressive disorder in 16-year-old adolescents. 
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4. Determine the relation between prenatal maternal anxiety and major depressive disorder 
in the offspring. 
5. Determine the correlations between maternal anxiety and depressive symptoms at 
prenatal, and 10, 14, and 16 year follow-up assessments. 
6. Characterize the longitudinal course of the children’s depressive symptoms.  
7. Determine the relation between prenatal maternal anxiety and depressive symptoms in 
the offspring from ages 10 to 16 years. 
 
The data are from the Maternal Health Practices and Child Development (MHPCD) 
project, a research program begun in 1982 that examines the long-term effects of prenatal 
substance use by women on their 763 singleton live-born offspring.  The women were selected 
from a hospital-based prenatal clinic and were of lower socioeconomic status.   In total, 1360 
women were recruited during their fourth prenatal month.  From these women, two cohorts were 
selected for studies of prenatal alcohol and marijuana use.  The selection criteria for the alcohol 
cohort were as follows:  women who drank alcohol at the rate of three or more drinks per week 
in the first trimester of pregnancy, and the next woman who drank less than that amount or who 
abstained.  For the marijuana cohort, the criteria for selection were as follows: women who used 
marijuana as often as twice a month, and the next woman who used less or abstained were 
selected.  Women may be in either or both cohorts.  These two cohorts were combined for this 
dissertation project, yielding a total of 829 women at the first assessment (fourth gestational 
month).  Subsequent assessments of the women were conducted at the 7th prenatal month, and 
with their child shortly after delivery, 8 and 18 months postpartum, 3, 6, 10, 14, and 16 years.  At 
the 16-year follow-up, the retention rate was 77% of the birth cohort. 
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A discussion of anxiety follows, including its epidemiology, definition, co-occurrence 
with depression, its relation to stress, and its covariates.  Following this will be a discussion of 
major depressive disorder in adolescents, its risk factors and important covariates.  Finally, the 
effects of prenatal maternal anxiety on offspring and potential mechanisms mediating these 
effects will be addressed. 
1.1 ANXIETY 
1.1.1 Epidemiology of Anxiety Disorders 
The National Comorbidity Survey Replication (NCS-R), which generates diagnoses according to 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV; APA, 1994), 
reported lifetime generalized anxiety disorder (GAD) estimates ranging from 4.2% (12-month 
minimum duration requirement) to 12.7% (1-month minimum duration requirement) (Kessler, 
Brandenburk, Lane, Roy-Byrne, Stang, Stein, & Wittchen, 2005).   
Much data on the distribution of anxiety disorders in the population is available from the 
Epidemiologic Catchment Area (ECA) study, one of the largest investigations of mental 
disorders in a community setting, and based on the older DSM-III (APA, 1980) criteria, which 
required a minimum duration of one month for GAD diagnosis (Kessler, McGonagle, & Zhao, 
1994; Regier, Narrow, & Rae, 1990). Marital status is significantly associated with anxiety 
disorder, as shown by sharply higher rates of disorder among the separated or divorced groups.  
Married, single, or widowed adults have lower one-month prevalence rates in the 6-7% range, 
whereas the rate for those who are separated or divorced is 11% (Regier et al., 1990).  There is 
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also a striking gradient by socioeconomic status.  There is a significant step-like increase in the 
one-month prevalence of anxiety disorders from the highest SES group (rate, 4.6%) to the lowest 
SES group (rate, 10.5%). (Regier et al., 1990). Prevalence rates of anxiety disorders additionally 
vary by age group, and peak between the ages of 25 and 44 years (one-month prevalence of any 
anxiety disorder, 8.3%) (Regier et al., 1990).  Although rates of anxiety disorders are lower in 
children than adults, these disorders nevertheless remain a significant problem.  Costello et al. 
reported 2.4% as the 3-month prevalence rate of any anxiety disorder in children aged 9-16 years 
(Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Anxiety disorders occur about twice as 
often in women (9.7%) as in men (4.7%) (one-month prevalence rates; Regier et al., 1990). 
Among all anxiety disorders, phobic disorders were found to be the most common sub-type in 
women (8.4% per month) (Regier et al., 1990).   
1.1.2 Trait Anxiety 
Clinical diagnosis of anxiety disorder differs from the measurement of anxiety symptoms.  In the 
clinical setting, instruments based on the DSM-IV, are used to establish the presence of a 
disorder.  To be diagnosed with an anxiety disorder, the patient must meet a minimal number of 
criteria.  However, the State-Trait Anxiety Inventory (STAI) measures state and trait anxiety on a 
dimensional scale such that anxiety may be detected along a continuum (Spielberger, 1983).  
Thus, researchers are able to quantify anxiety symptoms in individuals with sub-clinical anxiety.  
In a geriatric sample, high scores on the state scale of the STAI have been shown to distinguish 
those with a psychiatric disorder (including generalized anxiety disorder, mixed anxiety-
depression, depression, dysthymic disorder, and adjustment disorder) from those without a 
diagnosis (Kvaal, Ulstein, Nordhus, & Engedal, 2005). 
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Anxiety has been conceptualized in many ways in the literature as a trait, a state, a 
stimulus, a response, a drive, and a motive (Endler & Kocovski, 2001).  In 1966, Spielberger 
distinguished state from trait anxiety by defining trait anxiety as the individual’s predisposition 
to experience anxiety in a stressful situation, and state anxiety as a transient emotional response 
characterized by unpleasant feelings of tension and apprehensive thoughts (Spielberger, 1966).  
The STAI was developed to measure state and trait anxiety separately (Spielberger, 1983).  
Nevertheless, the two measures are highly correlated (Albrecht & Rankin, 1989).  Trait anxiety 
tends to be stable over time and its test-retest reliability is high (range 0.73 to 0.86) (Spielberger, 
Gorsuch, & Lushene, 1970).  The state-trait distinction continues to be used currently in 
psychometric assessments of anxiety.   
1.1.3 Co-occurrence of Anxiety and Depression   
There is controversy as to whether anxiety can be distinguished from depression, and vice versa.  
Regier and colleagues (1990) have found that 1.9% of the population has a clinical diagnosis of 
both an anxiety and depressive disorder during a six-month period.   
Because of the higher relative rates of anxiety disorders, the co-morbid group represents 33% of 
those with affective disorders and 21% of those with anxiety disorders over a six-month period.  
Furthermore, Kaneda and Fujii (2000) found that state and trait anxiety and depressive symptoms 
are all positively correlated in both normal subjects as well as in patients with clinical anxiety 
disorders.  They suggest that common mechanisms underlie the overlap in symptoms of anxiety 
and depression. 
Alloy and colleagues (Alloy, Kelly, Mineka, & Clements, 1990) have argued that in 
clinical samples, anxiety is usually an inherent feature of depression.  Others have argued that 
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self-report measures of anxiety and depression indicate a common construct of negative 
affectivity, neuroticism, or general psychological distress (Gotlib, 1984; Watson & Kendall, 
1989).  Others have argued that the constructs of anxiety and depression cannot be adequately 
differentiated using self-report measures (Dobson, 1985; Feldman, 1993).  Self-report measures 
such as the Beck Depression Inventory and STAI are highly correlated, with correlation 
coefficients ranging from 0.5-0.8 (Watson & Kendall, 1989).  Endler, however, has insisted that 
these findings are due to the limitations of the measures, rather than actual overlap of the two 
constructs (Endler & Kocovski, 2001).  Nevertheless, the fact remains that research on 
depression and anxiety is limited by the inability to separate each of these constructs.   
 The strong association between anxiety and depressive symptoms extends to pregnant 
women.  In a sample of women, one group found that higher trait anxiety was correlated with 
higher Beck Depression Index scores during pregnancy (Demyttenaere, Lenaerts, Nijs, & Van 
Assche, 1995).  More recently, it has been found that both, prenatally and postnatally self-
reported depressed women reported higher state and trait anxiety during pregnancy as compared 
to women who did not report elevated depressive symptomatology (Da Costa, Larouche, Drista, 
& Brender, 2000).  Furthermore, there are implications of prenatal anxiety for the postpartum 
period.  Barnett and Parker found that primiparous mothers with high prenatal state anxiety, were 
more depressed and more worried about themselves, their babies, and their marriage and had 
more doubts about their mothering capacity in the postpartum period (Barnett & Parker, 1986). 
1.1.4 Stress and Anxiety  
There is no universal definition of stress; various definitions exist for various contexts.  
Psychosocial stress is a complex construct, in that it is a “person-environment interaction” in 
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which there is a perceived discrepancy between environmental demands and the individual’s 
biological, psychological, or social resources (Lazarus & Folkman, 1986).  This comprehensive 
definition addresses the point of interaction between stimulus-focused and response-focused 
definitions of stress.  For example, stimulus-based stress research focuses on the stimulus by 
measuring life events whereas response-based stress research focuses on the individual’s 
response by using instruments which measure anxiety (Lazarus & Folkman, 1984).  Anxiety is a 
construct of perceived stress, and is related to the relative change or adjustment associated with a 
stimulus. 
From a biological perspective, stress is any challenge, physical or psychological, that is 
perceived to threaten homeostasis (i.e., the person’s internal harmonious equilibrium) (Chrousos 
& Gold, 1992).  In response to stress, a person’s neuroendocrine, immune, and vascular systems 
are activated.  Mild stress can be a positive stimulus to emotional and intellectual growth and 
development.  However, severe, protracted, or uncontrollable psychological distress can lead to a 
breakdown of homeostasis, and thus to disease.  For these reasons, stress is a widely studied 
phenomenon. 
There exist two related bodies of literature on stress/anxiety:  studies in humans and 
studies on animals.  In fact, many of the human studies are justified by biological findings from 
animal studies.  Animal models often measure physiological responses to stressful stimuli such 
as bright light or noise.  Similarly, various stressors in humans are associated with activation of 
primarily two physiologic systems:  the hypothalamic-pituitary-adrenal (HPA)-axis and 
sympathetic nervous system (catecholamine-autonomic) (Dimsdale & Moss, 1980; Tsigos & 
Chrousos, 2002).   Importantly, studies (e.g., Dimsdale & Moss, 1980) have found that self-
reports of increased anxiety correlate with exposure to the stressors.  Such findings in which 
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stressors are associated with physiologic reactions in animals and humans, as well as anxiety in 
humans, implicitly justify generalizing from laboratory-based models of the effects of stressors 
to anxiety.   
Although stress is often assessed on the basis of life event and anxiety questionnaires, 
some studies attempt to distinguish between stress, life events, and anxiety by using different 
measures for each. For example, one research group measured these variables in dental patients 
with periodontitis (Vettore, Leao, Monteiro da Silva, Quintanilha, & Lamarca, 2003).  They used 
the Stress Symptoms Inventory (SSI) to detect whether patients present with a clinical stress 
syndrome, the Social Readjustment Rating Scale (SRRS) to measure a number of stressful life 
events and their impacts, and the Spielberger State-Trait Anxiety Inventory (STAI) to measure 
the two dimensions of self-reported anxiety.  The authors found that it was not high scores on the 
stress measures, but rather high trait anxiety, which was significantly associated with periodontal 
disease.  Indeed, separate measurements of anxiety, stressful life events/stressors, and stress 
symptoms are necessary because the response to stressors in humans varies greatly across 
individuals; the stressor interacts with an individual’s trait anxiety, coping mechanisms, and 
social support (Lobel, 1994).  Even twenty years ago, researchers recognized that more important 
than the presence of stressful agents is how a person handles or copes with them when the 
stressor is present (Lazarus & Folkman, 1984).  Standardized measures of anxiety, such as the 
STAI, are a valuable means for studying stress response because of their high reliability and 
validity and because they offer norms against which to compare subjects’ scores. 
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1.1.5 Prenatal Maternal Anxiety and its Covariates 
Pregnancy stresses the adaptive capacities of the pregnant woman at the physiological, 
psychological, and social level (Carlson & LaBarba, 1979).  Indeed, many investigators have 
documented increased anxiety during pregnancy (Beck et al., 1980; Davids, deVault, & 
Talmadge, 1961). Stressors implicated in maternal anxiety during pregnancy which were 
identified early on by researchers included the following:  extensive contact with medical 
professionals (Mernissi, 1972), discontinuous contact with staff (Reid & Mellwaine, 1980), and 
repeated pelvic examinations (Fuller, Endress, & Johnson, 1979).  In women who have a 
tendency towards anxiety, the stresses of pregnancy may exacerbate these tendencies.  
Furthermore, positive correlations in pregnant women have been found between trait anxiety and 
age, education level, number of years married, number of children, and occupation level 
(Albrecht & Rankin, 1989).  The more highly anxious women in this study additionally reported 
decreased social support (associated with state anxiety) and fewer personal resources (associated 
with trait anxiety).  Over the past couple of decades, additional correlates of maternal anxiety 
during pregnancy have been identified including:  race, ethnicity, substance use, life events, 
social support, daily hassles, and adverse birth outcomes.  Some of these correlates of anxiety 
during pregnancy may be confounders of the relation between prenatal maternal anxiety and 
outcomes in offspring.  The proposed dissertation will investigate some of these correlates of 
prenatal maternal anxiety. 
1.1.5.1 Race  
Findings on the relation between race and prenatal anxiety are mixed.  Differences in second and 
third trimester anxiety levels were found between Caucasian and Hispanic groups in a large 
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sample of 689 African American, Hispanic, and Caucasian women (Lederman, Harrison, & 
Worsham, 1994).  Compared with the Caucasian group, Hispanic women reported significantly 
higher state and pregnancy-specific anxiety.  Pregnancy-specific anxiety in this study related to 
the well-being of the woman’s baby and herself in labor and delivery, and the role of 
motherhood.  By contrast, another study did not show any significant differences in state anxiety 
levels (measured in mid- and late-pregnancy) among the African American, Hispanic, and 
Caucasian low-income pregnant women (Norbeck & Anderson, 1989). 
1.1.5.2 Maternal Substance Use, Ethnic Group, and Life Events 
Anxiety may influence the expectant mother’s behaviors:  tobacco, alcohol, cocaine, and caffeine 
intakes are higher and nutrition is poorer in more anxious people (Ratliff-Crain & Kane, 1995; 
Singer, Salvator, Arendt, Minnes, Farkas, & Kliegman, 2002; Steptoe, Wardle, Pollard, Canaan, 
& Davies, 1996).  A strong correlation between lifetime anxiety disorders and substance use has 
been well-established in both the NCS and ECA studies (Kessler et al., 1996; Regier, Burke et 
al., 1990).  According to the results from a large co-morbidity survey, in which anxiety disorders 
were classified as either substance-induced or non-substance-induced, about 15% of individuals 
with at least one 12-month non-substance-induced anxiety disorder had a substance use disorder 
as well (Grant et al., 2004).  Thus, the direction of the relation between anxiety and substance 
use is not entirely clear. 
Furthermore, substance use and ethnic group appear to be significant covariates of 
prenatal maternal anxiety.  This relation is demonstrated from the results of a study of substance 
use in low-income pregnant women, in which Zambrana and Scrimshaw (1997) described intra- 
and inter-ethnic group differences in mean prenatal life events and trait anxiety score for each 
substance use pattern group.  For Mexican American and Mexican immigrant groups, those 
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women who smoked, used alcohol, or illicit drugs reported significantly more life events and 
anxiety than their counterparts who never used any substance.  For African American 
respondents, mean number of life events was also significantly higher for women who reported 
use of any drugs than for those who reported no drug use.  However, there was no within-group 
difference found for African American women on the mean anxiety score.  The authors 
additionally noted intriguing results between ethnic groups.  Among non-substance users, 
African American women reported more prenatal life events and more anxiety than the other two 
ethnic groups.  However, paradoxically, Mexican American and Mexican immigrant women who 
smoked cigarettes or used illicit drugs reported more anxiety and life events during pregnancy 
than African American women in the equivalent drug using groups.  Overall, the study showed a 
trend toward increased prenatal life events and associated anxiety for women who used 
substances during pregnancy, particularly illicit drugs or illicit drugs in combination with alcohol 
or tobacco.   
There have been only a handful of studies that have not found an association between 
substance use and anxiety.  For example, Albrecht and Rankin found that, in a sample of women 
from various socioeconomic, racial, and religious groups, there were no significant differences 
on the STAI between pregnant smokers and pregnant nonsmokers (Albrecht & Rankin, 1989).  
Despite this finding, the majority of the literature supports a correlation between substance use 
and anxiety disorders.  The time-ordering of the relation between substance use and anxiety is 
not clear.  Some evidence suggests that stressful, chronic life problems can contribute to 
substance use (Biener, 1987; Lillie-Blanton, Martinez, Taylor, & Robinson, 1993).  
Alternatively, it is possible that substance use during pregnancy leads to the women having more 
stressful life events and self-reported anxiety.   
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1.1.5.3 Social Support and Stress 
One group conducted a study of psychosocial factors as predictors of well-being in 360 women 
during pregnancy (Paarlberg et al., 1996).  They found that depressive symptoms and, to a lesser 
degree, anxiety during pregnancy, were associated with negative psychosocial factors, 
particularly a higher number of daily stressors and lower satisfaction with received social 
support.  This study’s findings confirmed those in a sample of pregnant women aged 20 to 40 
years, in which Albrecht and Rankin found that increased state and trait anxiety were each 
significantly associated with decreased social support (Albrecht & Rankin, 1989).  Furthermore, 
an intervention study found that assigning highly anxious primiparous mothers during the first 
postnatal year to social support intervention (professional support) significantly reduced state 
anxiety levels as compared with the control group (Parker & Barnett, 1987). 
1.1.5.4 Birth Outcomes 
Women who experience stress and anxiety during pregnancy have higher rates of adverse birth 
outcomes (Dole et al., 2003; Paarlberg, Vingerhoets, Passchier, Dekker, & Van Geijn, 1995; 
Rini, Dunkel-Schetter, Wadhwa, & Sandman, 1999).  While Barnett and Parker (1986) found 
that highly anxious mothers had more delivery complications, the most consistent findings are 
for preterm births and low birth weight.  One study showed that these two variables were 
significantly predicted by an indicator of stress (incorporating state anxiety, perceived chronic 
stress, and life event stress), after controlling for medical risk, parity, and maternal substance use 
(Lobel, Dunkel-Schetter, & Scrimshaw, 1992).  Furthermore, in Hedegaard and colleagues’ 
(Hedegaard, Henriksen, Sabroe, & Secher, 1993) cohort of several thousand women attending a 
prenatal clinic, psychosocial distress, as measured by the General Health Questionnaire 
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(Goldberg, 1972), during late pregnancy (30th  week), but not early pregnancy (16th week), 
predicted preterm delivery.   
1.2 DEPRESSION 
1.2.1 Major Depressive Disorder in Adolescents 
Major depressive disorder (MDD) accounts for greater mortality, morbidity, and financial costs 
than any other psychiatric disorder (Murray & Lopez, 1996).  Those who experience depression 
at an early age tend to struggle with the illness throughout their lives (Lewinsohn, Rohde, Klein, 
& Seeley, 1999).  There are many parallels between MDD in adults, adolescents, and children 
(e.g., Ryan, Puig-Antich, Ambrosini, Rabinovich, Robinson, Nelson, et al., 1987), however there 
are some key differences.  Symptoms of melancholia, psychosis, suicide attempts, lethality of 
suicide attempt, and impaired functioning are less common in younger patients. More common 
in earlier-onset  depression are symptoms of separation anxiety, phobias, somatic complaints, 
and behavioral problems (Carlson, & Kashani, 1988; Kolvin, Barret, & Bhate, 1991; Mitchell, 
McCauley, Burke, Moss, 1988; Ryan et al., 1987). People who develop depression in childhood 
and adolescence have more relapses, more serious disorders, and higher rates of comorbid 
psychiatric disorders (Lewinshon, et al., 1999).   
Adolescence is a time when many new cases of depression emerge.  Unipolar depression 
is more common in adolescence (1-year prevalence estimates range between 0.4% and 8.3%) 
than in childhood (1-year prevalence estimates range between 0.4 and 2.5%) (Fleming & Offord, 
1990; Birmaher, Ryan, Williamson, Brent, Kaufman, Dahl, et al., 1996; Lewinsohn, Clarke, 
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Seeley, & Rohde, 1994).  Furthermore, adolescence is a particularly crucial time of development 
because, in addition to experiencing puberty, the children experience social stressors that they 
may not have experienced during childhood.  Some adolescents may be better equipped to deal 
with the stressors than others, and the degree of their ability may contribute to their risk of 
developing depression.  For these reasons, it is crucial that we gain a better understanding of the 
risk factors associated with MDD in adolescents.   
1.2.2 Risk Factors for Depression 
1.2.2.1 Parenting and Parental Psychopathology 
In addition to the genetic contribution made by the parents, there is a strong environmental 
influence of the caregiver on child development and on development of psychopathology.  
Evidence suggests that responsive caregivers may help protect against depression and other 
forms of psychopathology (Nachmias, Gunnar, Mangelsdorf, Parritz, & Buss, 1996; Werner & 
Smith, 2001).  Indeed, the quality of the caregiver-child interaction has been determined to be 
one of the most important factors that distinguishes abused children with normal developmental 
outcomes from those with abnormal outcomes (Kaufman & Henrich, 2000; Pynoos, Steinberg, & 
Wraith, 1995). One study reported an association between parental expressed emotion and 
serious child and adolescent affective disorders (Schwartz, Dorer, Beardslee, Lavori, & Keller, 
1990).  They found that a higher degree of maternal critical expressed emotion predicted a 
threefold increase in the risk (odds ratio) for children aged 6-19 years to have at least one of the 
following DSM-III diagnoses: depressive disorder (MDD or dysthymia), substance use disorder, 
or conduct disorder.  More recently, Asarnow and colleagues (Asarnow, Tompson, Woo, & 
Cantwell, 2001) confirmed the findings of Schwartz et al. (1990) by demonstrating that maternal 
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emotion which is critical in nature (as measured by the Five Minute Speech Sample Expressed 
Emotion) shows some specificity as a risk factor for depression in youth (6-18 years of age)  
Several reviews have established that parental depression is a very strong predictor of 
depression during childhood and adolescence (Beardslee, Versage, & Gladstone, 1998; Downey 
& Coyne, 1990; Gelfand & Teti, 1990).  Consistent findings have come from longitudinal 
studies.  For example, Weissman et al. investigated the effects of parental depression over the 
course of a 10-year period (years 1, 2, and 10) on children aged 6-23 years at the beginning of 
the study (Weissman, Warner, Wickramaratne, Moreau, & Olfson, 1997).  At the 10-year follow-
up point, they found significantly higher rates of major depression, phobias, panic disorder, and 
alcohol dependence in the offspring of affectively ill parents as compared with offspring in the 
non-ill group.  However, even such well-designed longitudinal studies are potentially 
confounded by genetic risk of psychopathology. 
1.2.2.2 Genetics 
It is challenging to separate the specific effects of inheritance from those of the child’s 
environment.  Nevertheless, several authors have managed to find a role of genetics in 
depression.  Eaves et al. (1997) reported a substantial genetic effect on Depressive Disorder (as 
measured by the Child and Adolescent Psychiatric Assessment) among a large population-based 
sample of twin pairs aged 8-16 years.  In another study, prepubertal children with MDD had 
significantly higher familial rates of psychiatric disorders in first- and second-degree relatives 
than non-MDD controls (Puig-Antich, Goetz, Davies, & al., 1989).  Furthermore, Weissman et 
al. were one of the first groups of researchers to notice the trend that relatives of probands whose 
depression had an age of onset before 20 years, had higher rates of depression than the relatives 
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of probands with later onset of disorder (Weissman et al., 1984).  These early findings implied a 
genetic component to major depression that has an earlier onset.   
More recently, the role of genetics in childhood-onset MDD gained further support from 
Neuman et al’s findings, which used the Family History-Research Diagnostic Criteria (FH-RDC) 
assessment instrument to compare familial clustering of affective disorders among first-degree 
relatives of prepubertal versus adult probands with mood disorders (Neuman, Geller, Rice, & 
Todd, 1997).  They found that the cumulative risk for lifetime major mood disorders in first-
degree relatives of child probands was significantly higher than for relatives of adult probands.  
These findings indicate that there may be a larger genetic component in child-onset versus adult-
onset affective disorders.  Somewhat contradictory were the findings of Harrington et al.  In a 
thorough longitudinal study which followed probands from childhood to adulthood, the group 
found that, compared with prepubertal cases of depressive disorder, postpubertal forms of the 
disorder had a more specific association with a family history of depression and more 
continuities to major depression in adulthood (Harrington et al., 1997).  The prepubertal cases 
were instead more strongly associated with the environmental variable, family discord.  While it 
is evident that genetics does play a role in MDD, the relative contribution of genetics to child- 
versus adolescent- versus adult-onset is not clearly established.  
1.2.2.3 Demographics 
In a large, longitudinal study of families followed from infancy to adolescence, Spence et al. 
found that poverty, distressed marital relationship, and marital break-up during the child’s first 
five years produced small, but significant, increases in risk of high anxiety and depression 
symptoms in adolescence (Spence, Najman, Bor, O'Callaghan, & Williams, 2002).   
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The association between low socio-economic status and mental disorders, including 
depression, is well established (Johnson, Cohn, & Dohrenwend, 1999).  Furthermore, for 
depression, many study findings have supported a social causation, that is, adversity associated 
with low SES causes disorder (Dohrenwend, Levav, & Shrout, 1992; Johnson et al., 1999).  The 
theory of social causation for depression is in contrast to the alternate theory of social selection, 
proposed to explain some psychiatric disorders, which states that constitutional and 
environmental factors contribute to the onset of psychiatric disorders, which in turn cause 
individuals to experience downward drift in SES (Wender, Rosenthal, Kety, Schulsinger, & 
Welner, 1973).  Ritsher et al. were the first to control for parental depression in an inter-
generational test of social causation (i.e., low SES causes depression) (Ritsher, Warner, Johnson, 
& Dohrenwend, 2001). They found that low SES (measured by parental education and 
occupation), after controlling for parental depression, was associated with increased risk of 
depression in the offspring.   
Not all findings support the theory of social causation for depression.  For example, an 
income intervention study by Costello et al. failed to support the theory (Costello, Compton, 
Keeler, & Angold, 2003).  Over the course of eight years, 1420 rural children aged 9 to 13 years 
were given annual psychiatric assessments.  Halfway through this study, a casino opened on an 
American Indian reservation, which allowed 14% of study families to rise above poverty level.  
After the casino opening, there were significant decreases in conduct and oppositional defiant 
disorders in the child sample.   However, anxiety and depression symptoms were unaffected.  
These findings, which run counter to expectation, emphasize the importance of investigating the 
relation between poverty and specific psychiatric diagnoses and symptoms. 
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1.2.2.4 Gender & Age/Puberty 
Prior to adolescence, there is no additional risk for depression associated with either gender.  
However, when puberty begins, there is a sharp divergence by gender, with the rate among girls 
becoming approximately twice that among males (Angold, Costello, & Worthman, 1998). Both 
biological and social factors have been implicated in the predominance of depression among 
adolescent girls.  Hypotheses that have been proposed to explain the mechanism include: 1) 
Changing levels of various hormones, including testosterone and estrogen, may affect brain 
functioning; 2) Anatomic changes reflecting sexual maturity may influence social roles; 3) Other 
social changes may influence the number of depression-inducing life events; 4) Earlier pubertal 
timing of girls relative to male peers may cause social stress (Costello et al., 2002).  There is 
some evidence that suggests exposure to increased levels of testosterone and estrogen at puberty, 
especially in the context of social stress, independently predicts the risk for depression in girls 
(Angold, Costello, & Worthman, 1999; Silberg et al., 1999).   
1.2.2.5 Substance Use 
As with anxiety disorders discussed earlier, national epidemiology surveys (Kessler et al., 1996) 
and clinical studies (Swendson & Merikangas, 2000) have established the strong lifetime 
association of mood disorders with substance use disorders.  However, distinguishing between 
independent (i.e., non-substance-induced) and substance-induced mood disorders is challenging 
since diagnosis of current mood disorders among active substance users is complicated by the 
fact that many symptoms of intoxication and withdrawal from alcohol and other drugs resemble 
the symptoms of mood disorders.  In light of this challenge, recent work by Hasin and Grant 
separated past from current major depression in a large study of previous alcohol abusers, and 
showed that intoxication and withdrawal symptoms did not entirely account for the association 
  33
between alcohol use and depression (Hasin & Grant, 2002).  Even more recently, in the National 
Institute on Alcohol Abuse and Alcoholism’s National Epidemiologic Survey on Alcohol and 
Related Conditions (NESARC), the comorbidity of DSM-IV substance use disorders and nine 
independent mood and anxiety disorders was addressed (Grant, Moore, & Kaplan, 2003).   Grant 
et al. found that all independent mood disorders significantly correlated to alcohol and drug use 
disorders (OR 1.3-12.5) (Grant et al., 2004).  While these findings provide some insight into the 
prevalence and co-occurrence of mood disorders that are not substance-induced, questions 
regarding the mechanisms of comorbidity still remain.  Some evidence suggests that depression 
tends to precede substance use.  One recent prospective longitudinal study in a large sample of 
adults demonstrated that MDD significantly increased the risk for subsequent AUD (Gilman & 
Abraham, 2001).   
Existing literature also supports a significant association between substance use and 
depression in adolescents.  Consistent with the adult literature, Saluja et al. found through a 
school-based survey, that adolescents who use drugs have significantly higher levels of 
depressive symptoms (Saluja et al., 2004).  Elevated depressive symptoms have been shown to 
be risk factors for poor prognoses (e.g., Angst & Merikangas, 1997; Fergusson, Horwood, 
Ridder, & Beautrais, 2005; Lewinsohn, Solomon, Seeley, & Zeiss, 2000).  Saluja et al.’s study 
examined associations between depressive symptoms and specific types of drugs used by the 
adolescents in the 6th, 8th, and 10th grades.  The relative risks for having concurrent depressive 
symptoms were significantly greater than 1.0 for users of all substances examined, including 
tobacco (female, 2.8; male, 2.3), alcohol (female, 3.0; male, 2.5), marijuana (female, 2.6; male, 
2.2), cocaine (female, 2.5; male, 3.8), inhalants (female, 3.0, male, 4.0), and hallucinogens 
(female, 3.1; male, 3.0).   
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 While the association between adolescent depression and substance use is well-
established (Deykin, Levy, & Wells, 1987), the order of onset remains unclear.  In the Great 
Smoky Mountain Study data, depressive symptoms initially appeared between ages 9 and 11 
years, after the onset of alcohol use but before the onset of cigarette use (Costello, Erkanli, 
Federman, & Angold, 1999).  However, in youth who developed a depressive disorder by age 16, 
alcohol use had begun even earlier than in those youth without disorder (more than two years 
earlier in girls and one year earlier in boys).  Depressed boys were likely to begin to smoke 
cannabis one year after the onset of depressive symptoms and to develop cannabis abuse or 
dependence within another year, which was two years ahead of non-depressed boys.  In contrast, 
the Dunedin longitudinal study found a sex-specific pathway from early female depression to 
substance use at age 15 (Henry et al., 1993).  A prospective study by Williamson et al. which 
followed children through adolescence found that initially depressed children and children at 
high familial risk for depression had a nearly four-fold increase in risk for developing AUD by 
late adolescence compared with children at low familial risk for depression (Williamson et al., 
2005).  Furthermore, among children at high familial risk for depression, those who became 
depressed were five times more likely to develop AUD compared with those who did not 
develop depression.  Some studies, such as the Oregon longitudinal study have been unable to 
find any temporal relation between depression and alcohol use or dependence (Rohde, 
Lewinsohn, & Seeley, 1996).  Nevertheless, the literature has clearly established that substance 
use and depression in adolescents are highly correlated, and share common etiologies, including 
genetic and/or environmental factors (Burcusa, Iacono, & McGue, 2003; Prescott, Aggen, & 
Kendler, 2000). 
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1.2.2.6 Childhood Maltreatment, Violence Exposure, and Parental Substance Use 
Maltreatment includes various forms of abuse and neglect.  Childhood abuse and other stressful 
life events during childhood are associated with higher rates of MDD (Horesh, Sever, & Apter, 
2003; Kendler, Thornton, & Gardner, 2000; Kessler & Magee, 1993).  Population-based studies, 
including the large Adverse Childhood Experiences Study, document significant associations 
between depression (both, clinical depression and depressive symptoms) and abuse, neglect, and 
related forms of environmental adversity (Edwards, Holden, Felitti, & Anda, 2003; Famularo, 
Kinscherff, & Fenton, 1992; Kaufman, 1992).  A recent study discovered that effects of exposure 
to multiple forms of abuse (including verbal, emotional, sexual, and/or physical abuse) on 
depression in young adults were more than additive (Teicher, Samson, Polcari, & McGreenery, 
2006).   
The study by Teicher et al. (2006) also found strong effects on depression of witnessing 
domestic violence.  Another couple of related studies found that exposure to violence (including 
that in the home and community) predicts a diagnosis of a major depressive episode (MDE) in 
adolescents (Hanson, Self-Brown, Fricker-Elhai, Kilpatrick, Saunders, & Resnick, 2006; Self-
Brown, LeBlanc, Kelley, Hanson, Laslie, & Wingate, 2006).  Parental substance use (especially 
alcohol), a correlate of both child abuse and domestic violence, predicted MDE (Hanson et al., 
2006). Furthermore, parental substance use moderated the relation between abuse and depression 
in the adolescents. 
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1.3 MATERNAL AND OFFSPRING PSYCHOPATHOLOGY 
1.3.1 Effects of Prenatal Maternal Anxiety on Offspring 
Animal studies have demonstrated that prenatal stress can have direct long-term effects on the 
offspring’s ability to cope in stressful situations; prenatally stressed animals have prolonged 
elevation of plasma glucocorticoids in response to stressful and novel situations, thus indicating a 
dysregulated HPA axis (Henry et al., 1994; Weinstock, 1997; Schneider & Moore, 2000).  In 
humans, dysregulation of the HPA axis is thought to play a role in the etiology of MDD, 
however its role specifically in early-onset MDD is unclear (Arborelius et al., 1999; Holsboer, 
2000). 
Most of the extant studies on prenatal maternal anxiety and stress have focused on short-
term outcomes, such as preterm birth and low birth weight (e.g., Wadhwa, Sandman, Porto, 
Dunkel-Schetter, & Garite, 1993). There have been several studies additionally addressing the 
association between maternal anxiety and infant temperament.  For example, Van den Bergh 
(1990) assessed anxiety during each trimester of pregnancy in 30 women, and their infant’s 
temperament at 10 and 28 weeks of age.  She found that state anxiety during each trimester 
predicted infant temperament ratings.  Maternal anxiety primarily related to infant negative 
emotionality.  A few additional studies have followed the offspring of prenatally anxious 
mothers into early-middle childhood, but have measured only behavioral and emotional 
problems in these young children (Martin, Noyes, Wisenbaker, & Huttunen, 1997; O'Connor, 
Heron, Golding, & Glover, 2003).  Martin and colleagues (1997) in the Helsinki Longitudinal 
Temperament Project, a prospective study of 6,401 children, found a significant relation between 
prenatal maternal emotional distress (a latent variable including anxiety, depression, and mood 
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lability) and negative emotionality assessed in the offspring at age 5 years.  The major 
methodological limitation of this study, however, was that the measurement of preschool 
temperament was based on maternal report:  mothers in the study with a depressed or anxious 
predisposition may have experienced more distress during pregnancy, and viewed their children 
as exhibiting more negative emotionality.   
Recently, O’Connor and colleagues (2003) have shown through the Avon Longitudinal 
Study of Parents and Children (ALSPAC), a prospective community study, that prenatal 
maternal stress has a significant effect on the fetus that lasts at least into middle childhood, as 
evidenced by increased behavioral and emotional problems in 6 ½ year-old offspring of 
prenatally-anxious women.  Once again, this study is limited by use of maternal report of 
children’s behavioral/emotional problems.  Nevertheless, these significant findings in humans 
are consistent with the vast body of animal literature, which has found prenatal maternal stress 
effects on long-term behavior in the offspring.   
Another study (Van den Bergh & Marcoen, 2004) showed that, after controlling for key 
covariates, maternal state anxiety during pregnancy significantly predicted attention deficit 
hyperactivity disorder (ADHD) symptoms, externalizing problems, and self-report anxiety in 8- 
and 9- year olds.  Their outcome measures of symptoms were based on clinical questionnaires 
and standardized observation scales completed by mother, teacher, observer, and child.  Many 
additional studies of behavioral and emotional outcomes in prenatal anxiety/stress-exposed 
children have been comprehensively reviewed (Van den Bergh, Mulder, Mennes, & Glover, 
2005). 
A study by Allen and colleagues (Allen, Lewinsohn, & Seeley, 1998) examined prenatal 
and perinatal risk factors of psychopathology in adolescence.  The authors found that the two 
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perinatal variables that most strongly predicted MDD in the adolescents were maternal emotional 
health (anxiety and depressive symptoms) and not having breast fed the infant.  Prenatal 
maternal emotional health was no longer a significant predictor after adjusting for the mediating 
variable, maternal depression throughout the child’s lifetime.  This could suggest three 
possibilities.  The risk for adolescent depression is conferred by the effects of maternal 
depressive behavior throughout the child’s lifetime, a possibility supported by the literature 
(Downey & Coyne, 1990).  Alternatively, the association between maternal and child depression 
is due to a common environmental or genetic factor that influences both individuals.  A final and 
likely possibility is that, due to the retrospective design of the study, the women’s report of their 
emotional health during pregnancy (14 to 18 years prior) is biased by their current psychological 
state.  Because our data were gathered prospectively, we are able to overcome this limitation. 
Furthermore, we have separate measures of the pregnant women’s psychological health:  trait 
anxiety, trait anger, and depressive symptoms. 
1.3.2 Potential Biologic Mechanisms of Prenatal Maternal Stress /Anxiety 
As previously mentioned, the stress response (“fight or flight”) is mediated by several 
neurological and endocrine messages along both, the hypothalamic-pituitary-adrenal (HPA) axis 
and sympathetic nervous system (SNS).  Dysregulation of each of these systems has been 
implicated in depression (Arborelius et al., 1999; Holsboer, 2000; Ressler & Nemeroff, 2000).  
In the HPA-axis, stress perceived by the brain stimulates release of corticotrophin releasing 
hormone (CRH) and arginine vasopressin (AVP) from the hypothalamus, which in turn cause the 
release of adrenocorticotropic hormone (ACTH) from the pituitary.  ACTH then stimulates the 
release of cortisol, the major glucocorticoid in humans, from the adrenal glands.  Cortisol 
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enhances catabolic processes while suppressing anabolic pathways, to insure mobilization of 
energy stores.  The other major physiologic system activated in response to stress is the SNS.  A 
series of sympathetic nerves originate in the spinal cord and extend to the effector organs (e. g., 
heart, blood vessels, skeletal muscles, adrenal medulla).  At most sites in the body, the chemical 
transmitter is norepinephrine (noradrenaline). The adrenal medulla responds to sympathetic 
nervous impulses by secreting the catecholamine hormones (epinephrine and norepinephrine).  
The SNS activation results in increased pupil size, mobilization of fat and glycogen, heart rate, 
blood pressure, cardiac output, and a diversion of blood flow from the skin and splanchnic 
vessels (including those of the uterus), to supply the vessels in skeletal muscle. 
While short-term activation of the stress-response HPA-axis and sympathetic nervous 
systems are appropriate in times when a “fight or flight” response is required, prolonged 
activation may lead to several unhealthy consequences in the chronically stressed person, 
including suppression of anabolic processes, depletion of energy stores, and suppression of the 
immune system (Jacobson & Sapolsky, 1991; McEwen, 1995; Sapolsky, 1992).  With such 
negative consequences of elevated stress in the stressed person, himself/herself, one may 
speculate as to the effect of elevated stress in pregnant women on the developing fetus. 
 Stressed pregnant rodents have offspring with altered HPA-axis response, altered levels 
and distribution of neurotransmitters, including norepinephrine, dopamine, serotonin, 
acetylcholine, and modified limbic structures in the brain (see reviews by Kofman, 2002; 
Wadhwa, 1998; Weinstock, 2001).  Offspring of prenatally-stressed non-human primates have 
altered endocrine, immune, and neurobehavioral systems (Coe & Lubach, 2000; Schneider, 
Moore, Roberts, & Dejesus, 2001; Wadhwa, 2005).  Such physiologic changes decrease learning, 
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increase anxiety, and change social behavior (as evidenced by increased withdrawal) (Kofman, 
2002). 
Fetal programming results when an insult that occurs to the fetus during a critical period 
produces long-lasting or life-long effects on the organism (Lucas, 1994). The maternal-placental-
fetal neuroendocrine system, the HPA-axis, is thought to be the primary mediator of the effects 
of maternal stress on the fetus (Wahdwa, 2005).  In the fetus, glucocorticoids have dose-
dependent effects on morphologic development (Lederman, 1996).  The HPA axis is particularly 
susceptible to fetal programming by glucocorticoids (e. g., Barker, 1998).  Formation of the 
hypothalamus, pituitary, and adrenal glands occurs throughout gestation, with fetal HPA activity 
beginning at midgestation (Gitau, Fisk, Teixeira, Cameron, & Glover, 2001).  Elevated prenatal 
maternal cortisol levels may directly or indirectly impact HPA-axis development in the 
susceptible fetus.  The permanent modification of the HPA-axis in utero may lead to HPA-axis 
dysregulation throughout postnatal and childhood development, such that, when exposed to the 
stressors of adolescence, he/she is more susceptible to developing depression. 
Some elevation of plasma cortisol in pregnant women is normal.  There is a physiologic 
increase in maternal CRH levels from mid-second trimester of pregnancy, followed by a sharp 
rise in the last few weeks of pregnancy.  Additionally, the placenta secretes large amounts of 
CRH into maternal and fetal plasma during pregnancy, which regulates pituitary-adrenal function 
(Goland, Conwell, Warren, & Wardlaw, 1992).  In order to protect the developing fetus, the 
placenta contains the enzyme 11β-hydroxysteroid dehydrogenase Type 2 (11β-HSD2), which 
rapidly inactivates maternal cortisol before it enters fetal circulation (Lindsay, Linday, Edwards, 
& Seckl, 1996).  Thus, a direct action of maternal cortisol on the fetus is unlikely during the 
normal physiologic conditions of pregnancy.  The enzyme’s function under high levels of stress 
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and anxiety is unknown. Thus, it is possible that elevated prenatal maternal cortisol beyond 
normal pregnancy levels overwhelms the placental enzyme’s ability to inactivate the cortisol, 
such that the hormone reaches the fetus and directly modifies HPA-axis development.  An 
alternate mechanism is one involving action of fetal cortisol.  Levels of prenatal maternal cortisol 
positively correlate with fetal cortisol (Gitau, Cameron, & Fisk, 1998).  Cortisol has differential 
feedback effects, depending on the site considered.  In the hypothalamus, cortisol suppresses the 
release of CRH, whereas in the placenta, cortisol stimulates the expression of CRH (Laatikainen, 
1991).  This suggests a positive feedback mechanism between placental CRH and fetal cortisol 
and a mechanism that supports a maternal/fetal stress response (Lederman, 1996).  
Additionally, indirect mechanisms of maternal stress/anxiety have been suggested.  
Maternal anxiety during pregnancy is associated with decreased uterine blood flow (Teixeira, 
Fisk, & Glover, 1999).   Myers’ study of primates outlined a mechanism that explains this 
association: maternal exposure to stressors causes sympathetic activation and release of 
catecholamines into the blood stream, which reduce uterine blood flow, resulting in fetal hypoxia 
(Myers, 1977; Teixeira, Fisk, & Glover, 1999).  Other mediators may play a role in the 
hypothesized relationship between prenatal maternal anxiety and depression in the offspring.  
For example, prenatally stressed and anxious women have more birth complications 
(specifically, prematurity and low birthweight; Bhagwanani, Seagraves, Dierker, & Lax, 1997; 
Lou et al., 1994).  Indeed, it has been shown that premature delivery is a risk factor for 
developmental disorders (Den Ouden & Blanco, 2000).  It has not been shown that birth 
outcomes are mediators of a potential relation between prenatal maternal anxiety and 
psychopathology in the offspring. 
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1.4 SUMMARY OF PROPOSAL 
To my knowledge, there have been no previous prospective longitudinal studies 
investigating the role of prenatal maternal anxiety in predicting either depressive symptoms in 
late childhood and adolescence or lifetime diagnosis of major depressive disorder in adolescent 
offspring.  It is my aim to determine whether prenatal maternal trait anxiety, which does not 
necessarily constitute an anxiety disorder, can contribute to development of depressive 
symptoms in the offspring significant enough to constitute psychiatric disorder in adolescence.  
Thus, I hypothesize, in our cohort of women and their children from the MHPCD project, self-
reported prenatal maternal trait anxiety will significantly and positively predict diagnosis of 
MDD in the 16-year-old offspring, after controlling for current depressive symptoms in the 
mothers.  If, however, prenatal maternal anxiety does not significantly predict a lifetime 
diagnosis of major depressive disorder in the adolescents, I will modify my outcome to explore 
depressive symptoms at ages 10, 14, and 16 years. 
1.5 MANUSCRIPTS 
Three peer-reviewed manuscripts have resulted from the work presented in this dissertation. 
They are as follows: 
1. Hosseini, S. M., Wroble Biglan, M., Larkby, C., Brooks, M. M., Gorin, M. B., & 
Day, N. L. “Trait anxiety in pregnant women predicts offspring birth outcomes.”  
Chapter 2 is based on the work presented in this manuscript, which has been 
submitted to Paediatric and Perinatal Epidemiology. 
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2. Hosseini, S. M., Day, N. L., Brooks, M. M., Wroble Biglan, M., Gorin, M. B., & 
Larkby, C.  “Covariates of major depressive disorder in mid-adolescence.”  
Chapter 3 is based on the work presented in this manuscript, which will be 
submitted to the Journal of the American Academy of Child and Adolescent 
Psychiatry. 
3. Hosseini, S. M., Larkby, C., Brooks, M. M., Wroble Biglan, & Day, N. L.  
“Maternal anxiety symptoms during pregnancy predict depressive symptoms in 
children from ages 10 to 16 years.”  Chapter 4 is based on work presented in this 
manuscript, which will be submitted to the Journal of Child Psychology and 
Psychiatry. 
1.6 HYPOTHESES FOR MANUSCRIPTS 
Manuscript 1.  “Trait anxiety in pregnant women predicts offspring birth 
outcomes” 
I. The following variables will be significantly associated with higher PMA: 
a. Demographics 
H1: Less educated 
H2: Lower income 
H3: African American 
H4: Unemployed 
H5: Single  
b. Social/Other 
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H1: Less perceived social support  
H2:  More life events during pregnancy 
H3:  Any negative or neutral feelings about their pregnancy 
H4:  No church attendance 
c. Substance use (measured at each trimester)  
 H1: More marijuana 
 H2: More tobacco  
 H3: More alcohol  
 H4: Any illicit drugs (not including cocaine) 
 H5: Any cocaine 
d. Medical 
 H1:  More medical problems 
 H2: Lower gravida status 
 H3: More previous miscarriages 
 H4: Any hospitalizations during pregnancy 
 H5: Any illnesses during pregnancy 
e. Psychological 
 H1: Depressive symptoms 
 H2: Trait anger 
f. Adverse birth outcomes 
 H1: Lower birthweight 
 H2: Shorter birth length 
 H3: Smaller head circumference 
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 H4: Shorter gestational age 
 H5: More pregnancy complications 
 H6: More labor and delivery complications 
 H7: Small for gestational age (SGA) 
 H8: Lower than maximum Apgar score 
II. PMA measured at each assessment will predict adverse birth outcomes, after controlling 
for confounders in the other domains. 
III. PMA which is severe and chronic will have the greatest impact on birth outcome. 
 
Manuscript 2.  “Covariates of major depressive disorder in mid-adolescence” 
I. The following adolescent variables will bivariately be associated with MDD at age 16 
years:  
a. Demographics 
H1:  Female gender 
b. Social support 
H1: Fewer close friends 
H2: Lower frequency of outings 
c. Current substance use 
 H1: Any alcohol  
 H2: Any tobacco 
 H3: Any marijuana 
d. More severe childhood maltreatment (reported at age 16) 
e. More delinquent behavior 
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f. Pubertal status 
 H1: More advanced pubertal status at age 14 
 H2: Developed earlier than peers 
g. More anxiety 
h. Lower grade point average 
i. Poorer general health 
II. The following maternal variables will bivariately be associated with MDD at age 16 
years:  
a. Demographics 
 H1: Lower income 
 H2: Lower education 
 H3: Unemployment 
 H4: Single 
 H5: No male in household 
b. Psychological 
 H1: Higher trait anxiety  
 H2: More depressive symptoms 
 H3: Higher trait anger  
c. Psychiatric 
 H1: Major Depressive Disorder (MDD) 
H2: MDD only 
H3: Comorbid MDD 
H4: Any DSM-IV disorder other than MDD 
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H5: Generalized anxiety disorder (GAD) 
H6: Any alcohol disorder 
H7: Any marijuana disorder 
H8: Any cocaine disorder 
III. A multivariate model of MDD will include both offspring and maternal variables. 
 
Manuscript 3.  “Maternal anxiety symptoms during pregnancy predict depressive 
symptoms in children from ages 10 to 16 years” 
I. PMA is associated with depressive symptoms in the offspring. 
II. After controlling for confounders, PMA will remain a significant predictor of 
longitudinal depressive symptoms in the offspring. 
III. Potential mediators of the PMA/offspring depressive symptoms relation include: 
a. Adverse birth outcomes: 
i. Lower birthweight (or low birth weight) 
ii. Shorter birth length 
iii. Shortened gestational age (or preterm birth) 
iv. Small size for gestational age 
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2.0  MANUSCRIPT 1:  TRAIT ANXIETY IN PREGNANT WOMEN PREDICTS 
OFFSPRING BIRTH OUTCOMES 
2.1 SUMMARY 
The goal of our study was to characterize the relations between trait anxiety symptoms of women 
during their pregnancies and birth outcomes of offspring using a longitudinal cohort from the 
Maternal Health Practices and Child Development Project.  We used the State-Trait Personality 
Index (STPI) anxiety measure, based on Spielberger’s State-Trait Anxiety Inventory (STAI) to 
measure self-reported trait anxiety at two gestational assessments (fourth and seventh months) 
and at a third assessment shortly after delivery. Demographic, social, psychological, substance 
use, and medical factors were assessed prenatally, and outcomes of the 763 live, singleton births 
were determined at delivery.  In regression models, trait anxiety at the second and third 
assessments predicted lower birthweight and shorter birth length, controlling for confounds. 
Anxiety reported at the third assessment predicted shortened gestational age, controlling for 
confounds.  At the first and second assessments, the relation of birthweight and birth length to 
maternal trait anxiety was only significant for severe anxiety.  Women whose anxiety reached 
severe levels for at least two assessments were significantly more likely to deliver offspring of 
lower birthweight and shorter birth length than those women who reported severe anxiety at none 
or one of the assessments.  Additionally, offspring of women who experienced severe anxiety 
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during three trimesters had shorter mean gestational age compared to offspring of women who 
did not report severe anxiety at any assessment.  Women who report chronic, severe trait anxiety 
are at the highest risk of having shorter gestations and delivering smaller babies.  
2.2 INTRODUCTION 
Women who experience stress and anxiety during pregnancy are reported to have higher rates of 
adverse birth outcomes (Dole et al., 2003; Paarlberg, Vingerhoets, Passchier, Dekker, & Van-
Geijn, 1995; Rini, Dunkel-Schetter, Wadhwa, & Sandman, 1999), including lower 5-minute 
Apgar scores and more obstetric complications (Crandon, 1979a; 1979b). However, these studies 
and others focused on the effects of anxiety during pregnancy controlled only for some of the 
potential confounds of the relations between anxiety and birth outcomes (McDonald, Gynther, & 
Christakos, 1963; Ottinger & Simmons, 1964). 
More recent studies of birth outcomes have focused on determining the role of prenatal 
stress rather than that of anxiety.  Several of these have shown that prenatal stress predicted 
preterm births and low birthweight, outcomes that may have long-term implications for health 
(Bhagwanani, Seagraves, Dierker, & Lax, 1997; Lou et al., 1994) .Preterm delivery is a risk 
factor for developmental disorders (Den-Ouden & Blanco, 2000) and low birthweight has been 
shown to predict hypertension, insulin resistance, glucose tolerance, and cardiovascular disease 
(Barker, 1998a; 1998b).Lobel and colleagues found that prenatal stress (a combination of state 
anxiety aggregated over the course of pregnancy, perceived chronic stress, and life event stress) 
predicted preterm births and low birthweight, after controlling for medical risk, parity, and 
substance use (Lobel, Dunkel-Schetter, & Scrimsaw, 1992). Prenatal stress as defined in these 
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studies was composed of several variables, and only sometimes included trait anxiety.  
Therefore, it is unclear from these studies whether trait anxiety during pregnancy would predict 
shorter gestational age and smaller birth size of the offspring after potential confounds such as 
demographic factors, social support, substance use, medical problems, depression, and trait anger 
have been considered. 
Several mechanisms have been proposed to explain the link between stress and anxiety 
during pregnancy and birth outcomes.  First, anxiety may influence the expectant mother’s 
behaviors:  tobacco, alcohol, cocaine, and caffeine intakes are higher and nutrition is poorer in 
more anxious people (Ratliff-Crain & Kane, 1995; Singer et al., 2002; Steptoe, Wardle, Pollard, 
Canaan, & Davies, 1996).Each of these behaviors is associated with adverse birth outcomes, 
including preterm delivery and lower birthweight (Singer et al., 2002; Bloomfield et al., 2003; 
Bracken, Triche, Belanger, Hellenbrand, & Leaderer, 2003; Day et al., 1989; Windham, 
Hopkins, Fenster, & Swan, 2000). Second, maternal anxiety during pregnancy may increase fetal 
exposure to maternal glucocorticoids and lead to lower birthweight and higher glucocorticoid 
levels in offspring (Reynolds et al., 2001; Yehuda et al., 2005).Additionally, increased uterine 
artery resistance in anxious, pregnant women may lead to restriction of fetal nutrient supply and 
limit fetal growth (Lou et al., 1994; Teixeira, Fisk, & Glover, 1999).Further, compromised 
uteroplacental blood flow in anxious women activates the fetal hypothalamic-pituitary-adrenal 
(HPA) axis (Challis et al., 2001), which in turn, may prematurely activate the myometrium, 
resulting in delivery.  
We considered the relation of women’s anxiety at each trimester of pregnancy to birth 
outcome.  First, we explored whether anxiety was bivariately correlated with the following birth 
outcomes:  pregnancy, labor and delivery complications; birthweight, length, head 
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circumference, and gestational age; small-for-gestational-age (SGA); and the 5-minute Apgar 
score.  Bivariate associations of depression and trait anger, two variables that are highly 
correlated with anxiety, were also tested with respect to birth outcomes.  For each trimester, we 
determined whether trait anxiety predicted birth outcomes, after controlling for confounds in the 
following domains: demographic, social, substance use, medical, and psychological.  Among 
those birth outcomes predicted by anxiety in the multivariable models, we evaluated effects of 
both severity of anxiety and duration of severe anxiety.   
2.3 METHODS 
2.3.1 Study Design 
Data were obtained from the Maternal Health Practices and Child Development (MHPCD) 
Project, a longitudinal study begun in 1982 to examine the long-term effects of prenatal 
substance use on the physical and mental health of offspring.  Data used in our present analysis 
were collected from 1983 to 1985.  The women were selected from a hospital-based prenatal 
clinic and were of low socioeconomic status.   In total, 1360 women were recruited during their 
fourth prenatal month.  From these women, two cohorts were selected for studies of the effects of 
prenatal alcohol and marijuana use.  The selection criteria were as follows:  1) women who drank 
alcohol at the rate of three or more drinks per week in the first trimester of pregnancy, and those 
who drank less than that amount or who abstained; 2) women who used marijuana as often as 
twice a month, and those who used less or abstained.  Women could be in either or both cohorts.  
The present analysis combined these two cohorts, accounting for a total of 829 women at the first 
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assessment (fourth gestational month).  Subsequent assessments were obtained at the seventh 
prenatal month and at delivery.  Birth outcomes were obtained for 763 live-born singleton 
babies. The retention rate was 92%. The Institutional Review Board of the University of 
Pittsburgh approved the study and all women gave informed consent. 
2.3.2 Measurements 
Demographic factors, substance use, social, medical, and psychological status were measured at 
each of the three assessments.  Outcomes were measured at delivery. 
2.3.2.1 Demographics 
Racial status and age were self-designated by the participants at the first assessment.  Marital 
status, monthly income, employment status, and education were ascertained from the women at 
each time point.  The following variables were dichotomized:  race (African 
American/Caucasian), marital status (married/unmarried), and employment status (employed or 
in school/unemployed and not in school).  Age, monthly income, and education were treated as 
continuous variables for all analyses.  
2.3.2.2 Social & Other 
The perceived social support variable used in our analyses was a composite of the following 
questions asked of each woman at the fourth month assessment: 1) how frequently she talks to 
friends, 2) how frequently she talks to relatives, 3) if she has someone to turn to in times of need, 
and 4) how satisfied she is with the help from friends and relatives.  The women were also asked 
whether and how often they attended church.  Stressful life events were assessed at delivery by 
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asking the women to report events that occurred at anytime during pregnancy. Participants were 
asked to describe how they felt about their pregnancy; their responses to this question were then 
dichotomized into positive and negative/neutral groups. 
2.3.2.3 Substance Use 
At each assessment, women were asked to report their use during the past trimester of alcohol, 
cigarettes, marijuana, cocaine, and other illicit drugs.  The women were asked about the quantity 
and frequency of the usual, maximum, and minimum use of alcohol and marijuana.  Alcohol and 
marijuana use variables for all trimesters were log transformed in order to reduce skewness of 
the distributions.  Women were also asked about the quantity and frequency of tobacco, cocaine, 
and other illicit drug use.  The average daily number of alcoholic drinks, marijuana joints, and 
cigarettes used were calculated for each trimester and treated as continuous variables.  Because 
cocaine and other illicit drug use were low, these variables were dichotomized (any/none). 
2.3.2.4 Medical 
Maternal height, pre-pregnancy weight, and total number of physical health problems were 
obtained from the women’s medical charts and treated as continuous variables.  The women’s 
gravidity was obtained, as was number of previous miscarriages.  In order to reduce skewness of 
the distribution, the maximum category for number of miscarriages represented 4 or more.  Both, 
gravidity and number of miscarriages were treated as categorical variables.  Women were 
designated as having any illness or hospitalization during pregnancy at the time of delivery and 
this was treated as a dichotomized variable.  
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2.3.2.5 Psychological Measures 
Trait anxiety is defined as the individual’s predisposition to experience anxiety in a stressful 
situation, and state anxiety as a transient emotional response characterized by unpleasant feelings 
of tension and apprehensive thoughts (Spielberger, 1966). The two measures are highly 
correlated (Albrecht & Rankin, 1989). In this study, trait anxiety (score range: 10-40) and trait 
anger (score range: 10-40) were assessed at each study time point using the State-Trait 
Personality Inventory (STPI; Spielberger, 1979).  The items of the STPI are a subset of the 
parent scales, the State-Trait Anger Scale (STAS) (Spielberger, Jacobs, Russell, & Crane, 1983) 
and the State-Trait Anxiety Inventory (STAI) (Spielberger, 1983), both of which are used 
extensively.  Ten anxiety items and 10 anger items make up two subscales of the STPI.  The 
selection of items was based on the following criteria:  high corrected item-total correlations, 
relatively low item-scale correlations with the other subscale (anger vs. anxiety), and high factor 
loadings.  The trait anxiety and trait anger questions on the STPI assessed how MPHCD 
participants generally felt since the previous assessment, and in the case of the fourth prenatal 
month assessment, how they had felt since becoming pregnant.   
Depressive symptoms were assessed at each time point using the Center for 
Epidemiologic Studies-Depression Scale (CES-D; range: 0-60) (Radloff, 1977), a 20-item 
questionnaire that was developed to measure symptoms in both general and psychiatric 
populations.  As for the STPI, for the administration of the CES-D, the instructions were 
modified such that the women were asked to report how they had generally felt about each of the 
items since the previous assessment.   
Higher scores on each of the scales indicate more anxiety, anger, and depressive 
symptoms.  The sample mean of a particular question was used to replace missing data if, at 
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most, 10% of the responses to questions were missing (i.e., a maximum of 1 item for each of the 
anxiety and anger scales and a maximum of 2 items for the depression scale). Thus, for the first, 
second, and third trimester scores, 1 missing trait anxiety item was filled in for 20, 25, and 21 
women, respectively; 1 missing trait anger item was filled in for 6, 15, and 11 women, 
respectively; 1 missing depression item was filled in for 18, 25, and 26 women, respectively; and 
2 missing depression items were filled in for 5, 2, and 10 women, respectively.  
2.3.2.6 Birth Outcomes  
Pregnancy, labor, and delivery complications (Hobel, Hyvarinen, Okada, & Oh, 1973; Littman & 
Parmelee, 1978; Zax, Sameroff, & Babigian, 1977) were abstracted from the medical charts by 
trained nurse clinicians after delivery.  Examples of pregnancy complications include:  anemia, 
infections, hypertension, and abnormal bleeding.  Examples of labor complications include:  
precipitous labor, induction, pitocin augmentation, and preterm delivery.  Examples of delivery 
complications include: anesthesia, meconium stained fluid, nuchal cord, cesarian section, and 
forceps delivery.  The number of pregnancy complications was categorized as 0, 1, 2+.  Labor 
and delivery complications were combined and categorized as 0, 1, 2, 3, 4, 5+ complications.  
Infant birthweight (grams), birth length (centimeters), head circumference (centimeters), and 
gestational age (determined using the Dubowitz scale) were measured by study personnel who 
were trained to a standardized assessment and were monitored for reliability.  Small-for-
gestational-age (SGA) was defined as having a birthweight below the tenth percentile for 
gestational age.  The 5-minute Apgar score was taken from the medical record and dichotomized 
as follows: maximum score (9) and below maximum score (1-8). 
  56
2.3.3 Statistical Analyses 
2.3.3.1 Bivariate Analyses 
Confounds in the relations between anxiety and each of the birth outcomes were identified using 
bivariate analyses.  We report the association of each covariate with third trimester anxiety 
unless otherwise noted: This best reflects the final live-birth sample.  As a conservative 
approach, significant (p<0.05) as well as marginally significant (p<0.10) covariates of anxiety 
were tested for associations with the birth outcomes in order to increase the number of variables 
considered as potential confounds.  Further, because there was such a high correlation between 
anxiety, depression, and trait anger, we examined the bivariate associations between the birth 
outcomes and each of these psychological variables.  
2.3.3.2 Multivariate Regressions for Birth Outcomes 
Multivariate analyses were performed to provide quantitative results for all outcomes that were 
significantly associated with anxiety on a bivariate level during at least one trimester.  The 
analyses were done using a blocked entry stepwise multiple regressions.  All significant (p<0.05) 
confounds from the demographic, social, substance use, and medical domains were allowed to 
enter stepwise in the first block of the regression model.  The psychological variables (trait 
anxiety, depression, and trait anger) were then allowed to enter stepwise in the second block.  
Forward logistic regression was used for categorical outcomes that were bivariately associated 
with anxiety during at least one trimester in the bivariate analyses.  Parallel to the approach taken 
for the continuous outcomes, a two-block approach was used for these categorical outcomes.  
Separate regressions were run for each trimester to determine the effects of timing of anxiety.  
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Influential points were identified by residual analyses.  The final models contain all data points 
because the removal of influential points did not significantly affect the models. 
2.3.3.3 Severity of Anxiety 
Quartiles of anxiety were defined across pregnancy to provide descriptive analyses of the data.  
Mean values of birthweight, length, and gestational age were compared across these quartiles of 
anxiety using one-way ANOVAs with Tukey’s post hoc analyses.  Severe anxiety was defined as 
anxiety in the fourth quartile.   
2.3.3.4 Duration of Severe Anxiety 
To determine whether birth outcomes varied with the duration of severe anxiety throughout 
pregnancy, categories were defined as follows:  0) below the fourth (highest) quartile of anxiety 
for all three assessments; 1) in the fourth quartile for one assessment; 2) in the fourth quartile for 
two assessments; 3) in the fourth quartile for all three assessments.  Means of birthweight, 
length, and gestational age were compared across categories using one-way ANOVA with 
Tukey’s post hoc analyses. 
2.4 RESULTS 
2.4.1 Sample Description 
At delivery, the mean age of the women was 23 years (SD 4.0 years).  Sixty-seven percent of the 
women were single, 73% were unemployed, 51% were African-American, and 49% were 
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Caucasian.  Their mean education was 12 years (SD 1.4 years) and the median family income 
was $300-$399/month.  During the third trimester, the average daily volume of alcohol 
consumed by the women was 0.16 drinks (range 0-25).  On average, they smoked 9.2 (range 0-
70) cigarettes per day and 0.15 (range 0-9) marijuana joints per day during the third trimester.   
Other illicit drug use was rare:  approximately 1% in the third trimester.  Table 2-1. 
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Table  2-1 Sample characteristics and bivariate associations with trait anxiety during pregnancy 
 
Variable Mean (SD or range) or 
Percentage 
Association of variable with 
anxiety a,b 
 
Demographic:   
Age, years 23 years (4) -0.07, ns 
Proportion African American 51 t(758)=2.3* 
Median family income, $/month 300-399 -0.10** 
Proportion unemployed 73 t(755)=3.0** 
Proportion single  64 t(757)=1.0, ns 
Education, years  12 (1.4) ρ =-0.08* 
   
Social/Other:   
Perceived social support, # of people 3.3 (0.6) -0.26** 
Number of life events during pregnancy 1.7 (1.8) 0.08* 
Percentage with negative or neutral feelings 
about pregnancy 
17 t(758)=-6.2** 
Percentage attending church 37 F(760)=2.0, ns 
   
Substance Use for 1st trimester:   
Marijuana joints/day 0.39 (range, 0-9) ρ =0.03, ns 
Cigarettes/day 8.3 (range, 0-50) ρ =0.10** 
Alcoholic drinks/day 0.62 (range, 0-20) ρ =0.11** 
Percentage illicit drugs users 11 t(759)=-1.5, ns 
Percentage cocaine users 4 t(759)=0.4, ns 
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Table 2-1 (continued) 
 
Variable Mean (SD or range) or 
Percentage 
Association of variable with 
anxiety  a,b
Substance Use for 2nd trimester:   
Marijuana joints/day 0.14 (range, 0-6) ρ =0.11* 
Cigarettes/day 8.5 (range, 0-70) ρ =0.12** 
Alcoholic drinks/day 0.14 (range, 0-12) ρ =0.06, ns 
Percentage illicit drugs users 3 t(689)=-2.3* 
Percentage cocaine users 2 t(689)=-1.9, ns 
   
Substance Use for 3rd trimester:   
Marijuana joints/day 0.15 (range, 0-9) ρ =0.07, ns 
Cigarettes/day 9.2 (range, 0-70) ρ =0.08* 
Alcoholic drinks/day 0.16 (range, 0-25) ρ =0.03, ns 
Percentage illicit drugs users 1 t(758)=-1.3, ns 
Percentage cocaine users 1 t(758)=0.2, ns 
   
Medical:   
Maternal height, inches 64 (2.8) -0.14** 
Maternal pre-pregnancy weight, lbs 136 (33.7) -0.01, ns 
Medical problems 0.62 (0.9) 0.08* 
Gravida status 1.4 (1.5) F(760)=1.1, ns 
Previous miscarriages 3.1 (3.4) F(759)=1.9, ns 
Percentage hospitalized during 
pregnancy 
 
8 t(66)=-1.9, p<0.1 
Percentage ill during pregnancy 40 t(758)=-0.6, ns 
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Table 2-1 (continued) 
 
Variable Mean (SD or range) or 
Percentage 
Association of variable with anxiety  a,b
Psychological Scores for 1st trimester:   
CES-D Depression  
20.8 (8.7) 
 
0.71** 
STPI Trait Anger  
18.7 (5.7) 
 
0.56** 
   
Psychological Scores for 2nd trimester:   
CES-D Depression  
21.4 (8.1) 
 
0.73** 
STPI Trait Anger  
18.2 (5.3) 
 
0.58** 
   
Psychological Scores for 3rd trimester:   
CES-D Depression  
40.5 (8.5) 
 
0.71** 
STPI Trait Anger  
17.8 (5.3) 
 
0.60** 
   
Birth Outcomes:   
Birthweight, kg 3.20 (5.64) 
Birth length, cm 49.3 (2.5) 
Head Circumference, cm  
341 (15) 
Gestational Age, weeks  
39.7 (2.2) 
Pregnancy Complications  
1.0 (1.0) 
Labor and Delivery Complications  
2.4 (1.6) 
Small-for-gestational-age, % of babies  
10 
5 minute Apgar, % below maximum score  
13 
See Table 2a 
 
 
 
 
See Table 2a 
 
 
 
 
 
See Table 2a 
* p<0.05   ** p<0.01 
a Reported associations are with 3rd trimester anxiety, unless otherwise indicated. 
b Pearson correlation coefficients reported, unless otherwise noted. 
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2.4.2 Bivariate Analyses 
At the bivariate level, trait anxiety assessed at the third time point was associated (p<0.05) with 
the following demographic variables:  African-American race, lower family income, higher rate 
of maternal unemployment, and less education (Table 2-1).  Social variables associated with the 
third assessment of trait anxiety included less perceived social support and more life events 
during pregnancy.  In addition, women who were more anxious reported more negative/neutral 
feelings toward their pregnancy.  Anxiety in the first assessment was correlated with tobacco and 
alcohol use.  In the second trimester, anxiety was associated with tobacco, marijuana, and other 
illicit drug use.  During the third trimester, only tobacco use was correlated with anxiety.  
Medical variables associated with anxiety at the third assessment were shorter maternal height 
and a greater number of medical problems. Higher levels of depression and trait anger correlated 
significantly with trait anxiety at all trimesters.   
There were significant correlations between trait anxiety during at least one trimester and 
birthweight, length, and head circumference; shorter gestational age; more pregnancy 
complications, and a higher rate of SGA (Table 2-2).  The correlations between birth outcome in 
offspring and depressive symptoms in women were generally less strong than those for anxiety 
symptoms, with the exception of pregnancy complications being more strongly associated with 
depressive symptoms (Table 2-3).  Trait anger symptoms were less strongly correlated with the 
birth outcomes than either anxiety or depressive symptoms (Table 2-4). 
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Table  2-2 Bivariate associations of anxiety at each trimester with birth outcomes 
Birth Outcome 1st Trimester 2nd Trimester 3rd Trimester 
Birthweight -0.12** -0.13** -0.13** 
Birth length -0.09* -0.13** -0.13* 
Head Circumference -0.06, ns -0.09* -0.08* 
Gestational Age -0.06, ns -0.07, ns -0.10** 
Pregnancy Complications χ2(1)=4.9* χ2(1)=5.1* χ2(1)=4.8* 
Labor and Delivery 
Complications 
0.03, ns 0.04, ns 0.01, ns 
Small-for-gestational-age t(759)=-2.5** t(689)=-1.9, ns t(758)=-1.5, ns 
5 minute Apgar t(756)=-0.18, ns t(688)=-0.28, ns t(755)=-0.32, ns 
Pearson correlation coefficients reported, unless otherwise noted. 
* p<0.05, ** p<0.01, *** p<0.001 
 
Table  2-3 Bivariate associations of depression at each trimester with birth outcomes 
Birth Outcome 1st Trimester 2nd Trimester 3rd Trimester 
Birthweight -0.11** -0.10** -0.08* 
Birth length -0.07, ns -0.10* -0.08* 
Head Circumference -0.08* -0.07, ns -.06, ns 
Gestational Age -.06, ns -.06, ns -0.08* 
Pregnancy Complications χ2(1)=9.9** χ2(1)=5.9* χ2(1)=2.4, ns 
Labor and Delivery 
Complications 
0.07, ns 0.05, ns 0.06, ns 
Small-for-gestational-age t(755)=-1.6, ns t(686)=-0.13, ns t(748)=0.25, ns 
5 minute Apgar t(752)=1.6, ns t(685)=0.87, ns t(745)=0.52, ns 
Pearson correlation coefficients reported, unless otherwise noted. 
* p<0.05, ** p<0.01, *** p<0.001 
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 Table  2-4 Bivariate associations of trait anger at each trimester with birth outcomes 
Birth Outcome 1st Trimester 2nd Trimester 3rd Trimester 
Birthweight -0.06, ns -0.002, ns -0.08* 
Birth length -0.08* -0.02, ns -0.08* 
Head Circumference -0.04, ns -0.001, ns -0.05, ns 
Gestational Age -0.03, ns -0.01, ns -0.08* 
Pregnancy Complications χ2(1)=2.1, ns χ2(1)=0.13, ns χ2(1)=0.11, ns 
Labor and Delivery 
Complications 
0.05, ns 0.03, ns 0.05, ns 
Small-for-gestational-age t(759)=-1.2, ns t(689)=0.33, ns t(759)=-0.55, ns 
5 minute Apgar t(756)=-0.65, ns t(688)=0.23, ns t(756)=0.29, ns 
Pearson correlation coefficients reported, unless otherwise noted. 
* p<0.05, ** p<0.01, *** p<0.001 
 
2.4.3 Multivariate Regression Analyses 
All of the potential confounds were allowed to enter stepwise into the regression model.  In a 
second step, anxiety, depression, and trait anger scores were allowed to enter the model.  Anxiety 
in the first trimester did not predict birthweight, length or gestational age after confounds were 
considered.  However, both second (Table 2-5) and third trimester anxiety (Table 2-6) 
significantly predicted lower birthweight and shorter birth length, even after controlling for 
confounding variables.  Third trimester anxiety score predicted shorter gestational age (Table 2-
6).  For all three birth outcomes, neither depression nor trait anger was a significant predictor.  
Other significant predictors of birthweight included African American race and heavier 
cigarette use.  These same two variables, in addition to lower education and more life events, 
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also predicted shortened birth length.  There were no other significant predictors of shortened 
gestational age. 
The data in Tables 2-5 and 2-6 are reported as unstandardized Betas so effect sizes can be 
calculated.  For every five-point increase in the second trimester anxiety score, birthweight was 
decreased by 55 grams.  A five point increase in the third trimester anxiety score predicted a 66-
gram decrease in birthweight.  For every five-point increase in the anxiety scores in the second 
or third assessments, birth length was decreased by 0.2 cm.  Gestational age was shorter by 
approximately 1.6 days for each five-point change in the third trimester anxiety score.  
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 Table  2-5 Effect of second trimester anxiety on birth outcomes, after adjusting for confounds 
Outcome R-square change due to 
anxiety 
Unstandardized Beta 
(Δ outcome measurement for 5 point Δ anxiety score) 
Birthweight a  0.009***  -55.04 g 
Birth length b 0.006*  -0.19 cm 
Gestational age c ns  n/a 
 
Table  2-6 Effect of third trimester anxiety on birth outcomes, after adjusting for confounds 
Outcome R-square change due to 
anxiety 
Unstandardized Beta  
(Δ outcome measurement for 5 point Δ anxiety score) 
Birthweight a 0.008***  -65.50 g 
Birth length b 0.008*  -0.22 cm 
Gestational age c 0.009**  -0.23 wks 
a Other significant predictors of lower birthweight included:  African American race*** and heavier cigarette 
use***.  Depression, trait anger, education, work status, and alcohol use did not enter the model. 
b Other significant predictors of shorter birth length included:  African American race***, heavier cigarette use***, 
lower education**, and more life events*.  Depression, trait anger, social support and alcohol did not enter the 
model. 
c There were no other significant predictors of gestational age besides anxiety.  Depression and trait anger did not 
enter the model. 
* p<0.05, ** p<0.01, *** p<0.001
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2.4.4 Severity of Anxiety 
In these analyses, the anxiety scores were divided into quartiles for each assessment. At 
assessments 1 and 2, mean birthweight did not differ significantly across the lower three 
quartiles of anxiety.  However, the children of mothers in the top quartile of anxiety during the 
first assessment were lower birthweight (mean 3,066 g) compared to those of women in the first 
(3,269 g) and third (3,222 g) quartiles of anxiety (F(3) = 3.77, p<0.01; Figure 2-1).  Furthermore, 
mothers in the top quartile of anxiety during the second assessment delivered lower birthweight 
children (3,079 g) compared to women in the first three quartiles of anxiety (3,294 g, 3,250 g, 
and 3,283g, respectively; F(3) = 5.10, p<0.01).  We had similar findings for birth length at the 
first (F(3) = 2.70, p<0.05) and second (F(3) = 6.48, p<0.001) assessments (Figure 2-2).  By 
contrast, at the third assessment, with each quartile of anxiety, offspring birthweight (3,277; 
3,193; 3,133; 3,104 g; Figure 2-1) and birth length (49.5, 49.4, 49.0, 48.8 cm; Figure 2-2) 
appeared to decrease linearly.  None of the observed differences in gestational age between 
quartile groups were significant, although the data follow the same trend at each assessment as 
for birthweight and length, including a linear trend for the third assessment (40.0, 39.8, 39.6, 
39.4 weeks; Figure 2-3).   
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Figure  2-1 Effect of level of maternal anxiety on birthweight of offspring 
a Significantly different (p<0.05) from 4th quartile within the trimester  
b Significantly different (p<0.05) from 1st quartile within the trimester  
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Figure  2-2 Effect of level of maternal anxiety on birth length of offspring 
a Significantly different (p<0.05) from 4th quartile within the trimester  
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Figure  2-3 Effect of level of maternal anxiety on gestational age of offspring 
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 2.4.5 Duration of Severe Anxiety  
The effects of duration of severe anxiety on the birth outcomes are shown in Figures 2-4, 2-5, 
and 2-6.  Severely anxious women were categorized by the number of assessments, 0 through 3, 
at which they reported severe anxiety (anxiety score in the fourth quartile).  Offspring of women 
who experienced severe anxiety during three trimesters had lower mean birthweight (3,021 g, 
F(3) = 5.67, p<0.001; Figure 2-4) and shorter mean birth length (48.3 cm, F(3) = 6.16, p<0.001; 
Figure 2-5) compared to offspring of women who did not report severe anxiety at any trimester 
(3,278 g and 49.6 cm, respectively) and compared to women who reported severe anxiety during 
only one trimester (3,276 g and 49.6 cm, respectively).  There was a marginally significant 
(p=0.053) difference between offspring of those women with no severe anxiety and those who 
reported anxiety at two assessments (3,081 g and 48.7 cm).  Gestational age followed the same 
pattern as birthweight and length.  There were no significant group differences for either first or 
second trimester anxiety.  However, gestational age was significantly shorter for offspring of 
mothers who experienced severe anxiety during all trimesters, as compared with those who did 
not report severe anxiety at any of the assessments (39.4 vs. 40.0 weeks, F(3)=2.80, p<0.05; 
Figure 2-6).   
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Figure  2-4 Effect of severe anxiety duration on offspring birthweight 
a Significantly different (p<0.01) from “3 trimesters” group  
b Significantly different (p<0.05) from “3 trimesters” group  
c Marginally significant difference (p=0.052) from “2 trimesters” group 
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Figure  2-5 Effect of severe anxiety duration on offspring birth length 
a Significantly different (p<0.01) from “3 trimesters” group  
b Marginally significant difference (p=0.053) from “2 trimesters” group 
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Figure  2-6 Effect of severe anxiety duration on offspring gestational age 
 a Significantly different (p<0.05) from “3 trimesters” group 
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 2.5 DISCUSSION 
Trait anxiety measured in pregnant women at the second and third assessments predicted reduced 
birthweight and length after controlling for confounds.  Additionally, after controlling for 
confounds, anxiety during the third trimester predicted shorter gestational age.  Descriptive 
analyses demonstrated that in the first and second trimesters, the effects of anxiety were 
significant only among those women who had severe anxiety.  The association between level of 
third trimester anxiety and the severity of birth outcomes, however, appeared linear.  Our 
analyses of duration of anxiety indicate that women who experienced severe, chronic anxiety 
(i.e., in the top quartile of anxiety during at least 2 assessments) delivered significantly smaller 
babies, indicating that these women are of the greatest concern.   
African American race and heavier cigarette use also predicted lower birthweight and 
shortened birth length, which is consistent with prior literature that African American women 
(Collins & Hammond, 1996) and cigarette users (Windham et al., 2000) deliver smaller babies.  
Additional significant predictors of birth length included lower education and more stressful life 
events. 
Our finding that trait anxiety during pregnancy predicts smaller babies is consistent with 
reports that elevations in stress-related hormones suppress production or release of growth 
hormone in the fetus (Clapp, 1992). Furthermore, similar to our findings for shortened gestation 
length, Wadhwa and colleagues reported a relationship between stress and preterm birth, 
adjusting for confounding variables (Wadhwa, et al., 2001). Another group found that a decrease 
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in perceived stress among pregnant women during the second trimester was associated with 
increased gestation age (Ruiz, Fullerton, Brown, & Schoolfield, 2001). 
We found that anxiety during the third trimester predicted shorter gestational age.  The 
consistency of our findings with those of other studies supports the validity of the effects of third 
trimester anxiety.  In Hedegaard and colleagues’ cohort of several thousand women attending a 
prenatal clinic, psychosocial distress (anxiety and depression), during late pregnancy (30th week), 
but not early pregnancy (16th week), predicted preterm delivery (Hedegaard, Henriksen, Sabroe, 
& Secher, 1993). Both gestational age and baby size were predicted by anxiety reported at the 
third assessment in our study, which suggests that reduction in birth size associated with anxiety 
is better explained by a reduction in gestation length than by intrauterine growth retardation.  
Several studies have suggested that corticotrophin releasing hormone (CRH) controls the timing 
of labor and delivery (McLean et al., 1995; Sandman, Wadhwa, Chicz-DeMet, Dunkel-Schetter, 
& Porto, 1997). A marked increase in maternal plasma levels of ACTH and cortisol in the third 
trimester may trigger early labor and delivery (Ruiz, et al., 2001; Wadhwa, Porto, Chicz-De-Met, 
& Sandman, 1998). 
Our study was limited by the fact that measures of third trimester trait anxiety were 
ascertained from the mother within the first two days after delivery; thus her report of trait 
anxiety so close to delivery may reflect state anxiety related to the stress of delivery and to 
concern over a preterm delivery and/or smaller baby.  Despite this limitation in the timing of the 
third assessment, a major strength of our study was our choice of the independent variable:  trait 
anxiety.  We analyzed trait anxiety separately from depression, trait anger, social support, and 
stressful life events, in contrast to Rini and colleagues (Rini, et al., 1999), who combined 
measures of state and pregnancy-specific anxiety into a measure of prenatal psychosocial stress.  
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Our approach allowed us to try to assess the independent contribution of trait anxiety to birth 
outcome while controlling for other psychological stressors.  Nevertheless, while trait anxiety 
was a stronger predictor of birthweight, length, and gestational age than either trait anger or 
depression, we must keep in mind that these measures are highly correlated. 
The effects on birth outcomes among offspring of severely anxious and chronically 
severely anxious women in our cohort are not clinically significant.  Even the most severely 
affected women in our cohort (i.e., those in the highest severity and longest duration anxiety 
groups) delivered offspring whose average birthweight was approximately 3.0 kg, which is well 
above the cut-point for low birthweight (2.5 kg).  Likewise, the average gestation for offspring of 
severely anxious and chronically severely anxious women is approximately 39.4 weeks, which is 
clearly above the 37-week cut-off for preterm delivery.  These means are significant, however, 
when viewed from a population basis, where changes in outcome shift the entire mean of the 
cohort downward.  Furthermore, though small, these decreases in birth size and gestational age 
may affect the mental well-being of the child later in life (Record, McKeown, & Edwards, 1969; 
Matte, Bresnahan, Begg, & Susser, 2001; Richards, Hardy, Kuh, & Wadsworth, 2001). 
Low to moderate levels of anxiety in women during either the first or second trimester 
did not significantly affect the birth outcomes, but women who are severely anxious during much 
of their pregnancy should be considered for anxiety-reducing interventions.  Our finding that 
anxiety affected birth outcome points to the need of assessing whether prenatal care that 
addresses the psychological well-being of pregnant women would result in improved birth 
outcomes.  Anxious women should be identified early in or even prior to pregnancy and targeted 
for anxiety reduction.   
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3.0  MANUSCRIPT 2:  COVARIATES OF MAJOR DEPRESSIVE DISORDER IN 
MID-ADOLESCENCE 
3.1 SUMMARY 
The objective of this paper was to determine the covariates of Major Depressive Disorder 
(MDD) among low socioeconomic adolescents.  Data come from the Maternal Health Practices 
and Child Development (MHPCD) Project, a longitudinal study of mothers and their offspring.  
Domains of data include demographic, social, substance use, biological, psychological, and 
psychiatric measures.  Offspring and mothers were assessed for a lifetime diagnosis of MDD 
using the Diagnostic Interview Schedule-IV (DIS-IV) and DSM-IV criteria.  Significant 
adolescent and maternal covariates of adolescent MDD were determined using logistic 
regression. 
The prevalence of MDD among the 16-year-old adolescents was 13 %.  Female gender 
(adjusted OR 3.77, 95% CI 2.00-7.12), history of severe childhood maltreatment (third tertile of 
Child Trauma Questionnaire score, adjusted OR: 3.88, 95% CI 1.82-8.26), and maternal 
diagnosis of MDD (adjusted OR 1.80, 95% CI 1.02-3.18) were significant covariates.  There was 
a significant interaction between offspring gender and maternal MDD (OR 4.58, p<0.05).  
Female gender, a history of childhood maltreatment, and maternal history of MDD increased the 
odds of MDD in adolescents.  Daughters of women with a history of MDD are particularly 
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vulnerable. These risk factors should prompt early screening and intervention for these 
adolescents.  
3.2 INTRODUCTION 
Major depressive disorder (MDD) accounts for greater mortality, morbidity, and financial costs 
than any other psychiatric disorder (Murray & Lopez, 1996).  Those who experience depression 
at an early age struggle with the illness throughout their lives (Lewinsohn, Rohde, Klein, & 
Seeley, 1999).  Many new cases of depression emerge in adolescence.  The one-year prevalence 
of unipolar depression among adolescents is between 4% and 7%, whereas in children it is about 
2% (Costello, Erkanli, Federman, & Angold, 2002). People who develop depression in childhood 
and adolescence have more recurrences of depression, and higher rates of comorbid psychiatric 
disorders as young adults (Lewinsohn et al., 1999). Thus, understanding the risk factors 
associated with MDD in adolescents is critical.    
Correlates of adult MDD have been identified.  Many, such as substance use (Kessler, 
Nelson, McGonagle, Edlund, Frank, & Leaf, 1996; Swendson & Merikangas, 2000) and family 
history of depression (Kendler, Neale, Kessler, Heath, & Eaves, 1997) are well-established.  
Childhood abuse, neglect, and stressful life events are also associated with higher rates of MDD 
in adulthood (Horesh, Sever, & Apter, 2003; Kendler, Thornton, & Gardner, 2000; Kessler & 
Magee, 1993).   
Fewer studies have identified the covariates of MDD during adolescence. Demographic 
characteristics associated with adolescent MDD include female gender (Costello et al., 2002; 
Kessler & Magee, 1993; Burke, Burke, Regier, & Rae, 1990) and poverty. One study found that 
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those with juvenile-onset depression were more likely than those with adult-onset depression to 
have a history of perinatal insults, caregiver instability, criminality, and a family history of 
psychopathology (Jaffee, Moffitt, Caspi, Fombonne, Poulton, & Martin, 2002).  Parental 
depression (Beardslee, Versage, & Gladstone, 1998; Downey & Coyne, 1990; Gefland & Teti, 
1990) and parental marital problems, especially in the first three years of the child’s life (Spence 
& Najman, 2002) are significant predictors of MDD. This increased family risk is due to a 
combination of genetic and environmental influences (Eaves, Silberg, Meyer, Maes, Simonoff, 
Pickles, et al., 1997).  
This paper identifies the significant correlates of MDD in a racially-balanced, low 
socioeconomic status cohort of adolescents.  We hypothesized that adolescent variables in the 
domains of demographics, social support, substance use, childhood maltreatment, delinquent 
behavior, puberty, anxiety, academic performance, and general health, in addition to maternal, 
psychological, and psychiatric status would be associated with adolescent MDD.   
3.3 METHOD  
3.3.1 Study Design 
The MHPCD Project is a longitudinal study begun in 1982 to examine the long-term effects of 
prenatal substance exposure on the offspring.  The women were selected from a prenatal clinic 
and were of lower socioeconomic status.   In total, 1360 women were recruited during their 
fourth prenatal month.  From these women, two cohorts were selected for studies of prenatal 
alcohol and marijuana use.  The selection criteria for the alcohol cohort were:  women who drank 
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alcohol at the rate of three or more drinks per week in the first trimester, and the next woman 
who drank less than that amount or who abstained.  For the marijuana cohort, women who used 
marijuana as often as twice a month, and the next woman who used less or abstained were 
selected.  Women could be in either or both cohorts.  This analysis combined the two cohorts, for 
a total of 829 women at the fourth gestational month.  Subsequent assessments were at seven 
months and delivery. At delivery, 763 women and their babies were evaluated.  Later 
assessments of the mothers and children were at 8 and 18 months, 3, 6, 10, 14, and 16 years.  The 
Institutional Review Boards of Magee-Womens Hospital and University of Pittsburgh approved 
the study.  All women gave signed, informed consent for themselves and their children. 
3.3.2 Sample 
At 16 years, 592 caregivers and their children were interviewed. The retention rate was 78% of 
the birth cohort; 52 mothers refused assessment, 69 were lost, 35 had moved out of the area, 5 
children were in foster care, 1 child was institutionalized, 3 children were adopted, and 6 
children died.  There were no differences on maternal age, income, or education among those 
who were assessed at the 16-year phase compared to those who were not assessed.  The group 
that was not assessed had significantly more Caucasians (60%) than those who were assessed 
(45%).   
This analysis was limited to caregivers who were biological mothers (n=509).  Among 
these, a structured diagnostic interview was available for 499 child/mother dyads.   
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3.3.3 Measurements 
Adolescent social support, substance use, history of maltreatment, delinquent behavior, pubertal 
status, anxiety, grade point average, and general health were measured at the 16-year phase, as 
were maternal demographic, psychological, and psychiatric characteristics.   
3.3.3.1 Adolescent Variables: 
Major Depressive Disorder 
Lifetime diagnosis of MDD was assessed with the Diagnostic Interview Schedule, version IV 
(DIS-IV; Robins, Cottler, Bucholz, & Compton, 1995; Robins, Cottler, Bucholz, Compton, 
North, & Rourke, 2000).  A diagnosis was given if the adolescent had at least one occurrence of 
MDD prior to or concurrent with assessment.   
Demographics 
Adolescent age, race (African American/Caucasian) and gender were collected.   
Current Social Support 
Adolescents were asked how many close friends they had (none, 1, 2, 3 or more).  They were 
also asked how often they went out with their friends (none, 1, 2 or more times per week).   
Current Substance Use 
Adolescents reported their use of alcohol, cigarettes, marijuana, and other illicit drugs during the 
past month.  The distribution of substance use was positively skewed and non-use rates were 
high (43% reported no alcohol use, 58% reported no marijuana use, 59% reported no cigarette 
use), so use of each substance was analyzed as a dichotomous variable (none versus any use).   
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Childhood Maltreatment 
The Childhood Trauma Questionnaire (CTQ; Bernstein & Fink, 1993) assessed childhood abuse 
and neglect.  The CTQ, a 25-item self-report inventory, screens for a childhood history of 
emotional, physical, and sexual abuse, emotional and physical neglect.  Item scores range from 
“never true” to “very often true” on a 5-point scale.  The score is summed across items and 
ranged from 25 to 125.  The lowest score represented no history and the highest scores indicated 
severe childhood maltreatment.   
Additionally, the CTQ has a three-question “denial scale” that detects respondents who 
give exaggerated or desirable responses. These items were not included in the total score. Ninety 
who reported greater than one of these as being “very often true,” were removed from the 
analyses. Those removed were comparable in age and gender to those kept in the analyses except 
that significantly more African Americans (65%) were in the removed group, compared to the 
remaining group (65% vs. 53%, respectively).   
Delinquent Behavior 
The Self-Report Delinquency Scale (SRD; Elliot, Huizinga, & Ageton, 1985) measured 
delinquent behavior in each of five categories:  status offenses, theft, property damage, drug 
selling, and violence.  The subscales were summed to obtain a total score.  
Puberty 
At age 14, adolescents reported their pubertal status on the Pubertal Development Scale 
(Petersen, Crockett, Richards, & Boxer, 1988).  Scores range from 1 (pre-puberty) to 5 (post-
puberty).  A score of 3 separated those who were pre-pubescent and in early puberty from those 
who were in advanced puberty and post-pubertal.  Because so many of the girls at age 14 were 
above this cut-point, we used an additional measure of earlier maturation.  At age 16, the 
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adolescents rated their development relative to others their age from “much earlier,” to “much 
later.” This variable was categorized as “developed earlier” and “developed same or later”.   
Psychological & Physical Health  
Current anxiety in the adolescents was measured by the Revised Children’s Manifest Anxiety 
Scale (RCMAS; Reynolds & Richmond, 1978), a 28-item self-report inventory.  Scores ranged 
from 0 to 28.  Grade point average (GPA) was used as an indicator of academic performance.  
Finally, adolescents were asked to rate their general health from poor to excellent.  Few 
teenagers reported poor or fair health, and these two groups were combined, making four 
categories.  
3.3.3.2 Maternal Variables: 
Demographics   
Education was summarized as three groups: <12, 12, and >12 years.  Marital status 
(married/unmarried), employment status (employed/unemployed), and adult male in the 
household (yes/no) were considered.  Missing data were rare and were replaced with sample 
means for family income (n=2) and maternal education (n=1).    
Psychological 
Trait anger and trait anxiety symptoms were assessed at each phase using the State-Trait 
Personality Inventory (STPI; Spielberger, 1979).  The items of the STPI are a subset of the STAS 
(State-Trait Anger Scale; Spielberger, Jacobs, Russell, & Crane, 1983) and the STAI (State-Trait 
Anxiety Inventory; Spielberger, 1983),  The STPI trait anxiety and trait anger scores each ranged 
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from 10 to 40.  The sample mean was used to replace a single missing item on the trait anxiety 
(n=10) and trait anger scales (n=9).  
Depressive symptoms were assessed using the Center for Epidemiologic Studies-
Depression Scale (CES-D; Radloff, 1977), a 20-item questionnaire.  Scores range from 0 to 60.  
Sample means were substituted for individual answers for 19 women who each had 1 missing 
item and for 4 women who had 2 missing items on this scale.  
Psychiatric Diagnosis 
We used the DIS-IV (Robins et al., 1995; Robins et al., 2000) to assess lifetime history of DSM-
IV disorders.  For the analyses, MDD diagnoses were used in total (MDD only plus comorbid 
MDD) and separated into two mutually exclusive groups (MDD only, and MDD comorbid with 
other psychopathology).  Other diagnoses were grouped as follows: 1) generalized anxiety 
disorder (GAD), 2) any alcohol, marijuana, or cocaine disorder and, 3) any psychiatric disorder 
other than MDD.  The categories of substance use disorders (SUDs:  abuse, dependence, and 
withdrawal) were combined for each substance.   
3.3.4 Data Analyses 
Continuous data were categorized by tertiles or quartiles.  For each variable, the bivariate odds of 
adolescent MDD were calculated for the discrete categories using the lowest risk group as the 
reference group.  Variables associated (p<0.10) with adolescent MDD in the bivariate analyses 
were candidates for the multivariate model.  Stepwise logistic regression was used with an entry 
p-value of 0.05.  Child anxiety score was not included because it was highly correlated with the 
MDD diagnosis.  Goodness of fit was evaluated using the Hosmer-Lemeshow test.   
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After the main effects model was constructed, interaction effects between each pair of 
covariates were tested.  An interaction term was included in the logistic regression model only if 
it was statistically significant (p<0.05).  The potential mediation of the relation between 
childhood maltreatment and adolescent MDD by adolescent substance use was first examined 
using Baron and Kenny’s Causal Step test (Baron & Kenny, 1986; Judd & Kenny, 1981). 
3.4 RESULTS  
3.4.1 Bivariate Analyses 
Among the 499 adolescents in this study, 65 (13.0%) had a lifetime diagnosis of MDD, including 
7% of the boys and 18.7% of the girls.  The majority of cases had an onset of MDD at 11 years 
or later (mean=13.8 years, SD=2.5, range: 1 to 17 years old).  The odds of MDD were 
significantly higher in females (OR 3.04, 95% CI 1.70-5.45) and adolescents who had at most 
one close friend (2.17, 1.05-4.50) (Table 3-1).  Adolescents who were alcohol (1.87, 1.07-3.27) 
or tobacco users (1.77, 1.05-2.99), had a history of severe maltreatment (3.23, 1.55-6.73), 
moderate (3.62, 1.28-10.29) or severe (11.55, 4.36-30.60) anxiety symptoms, and poor or fair 
general health (3.95, 1.78-8.77) were significantly more likely to have MDD.  Age, race, 
frequency of social outings, marijuana use, delinquent behavior, pubertal status, self-perception 
of pubertal timing, and GPA were not significant.   
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 Table  3-1 Adolescent characteristics: Unadjusted odds ratios for adolescent MDD 
                                     N             Non-MDD           MDD               Odds Ratio                95% CI for  
                                                          (%)                   (%)                    (OR)                           OR 
Total Cohort                499        434 (87.0)           65 (13.0) 
Demographic Factors 
Age quartiles at assessment 
1st  ≤16.3             
125 113 (90.4) 12 (9.6) 1.00  
2nd 16.3-16.8      
127 111 (87.4) 16 (12.6) 1.36 0.61-3.00 
3rd 16.8-17.2 
124 106 (85.5) 18 (14.5) 1.60 0.74-3.48 
4th  ≥17.2 
123 104 (84.6) 19 (15.4) 1.72 0.80-3.72 
Race  
Caucasian  
 
229 
 
198 (86.5) 
 
31 (13.5) 
 
1.00 
 
African 
American  
270 236 (87.4) 34 (12.6) 1.09 0.65-1.83 
Gender 
Male  242 225 (93.0) 17 (7.0) 1.00  
Female  257 209 (81.3) 48 (18.7) 3.04*** 1.70-5.45 
Social Support 
Number of close friends 
≥ 3 252 223 (88.5) 29 (11.5) 1.0  
2 188 165 (87.8) 23 (12.2) 1.07 0.60-1.92 
1 or 0 59 46 (78.0) 13 (22.0) 2.17* 1.05-4.50 
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Table 3-1 (continued)  
Frequency of outings 
≥ 2 306 272 (89.2) 33 (10.8) 1.0  
1 134 112 (83.6) 22 (16.4) 1.63 0.91-2.91 
none 59 49 (83.1) 10 (16.9) 1.69 0.78-3.65 
 
Current Substance Use 
Alcohol use (drinks/day) 
None 217 197 (90.8) 20 (9.2) 1.00  
Any 282 237 (88.4) 45 (11.6) 1.87* 1.07-3.27 
Cigarette use (number/day) 
None 297 266 (89.6) 31 (10.4) 1.00  
Any 199 165 (82.9) 34 (17.1) 1.77* 1.05-2.99 
Marijuana use  (joints/day) 
None 292 258 (88.4) 34 (11.6) 1.00  
Any 205 174 (84.9) 31 (15.1) 1.35 0.80-2.28 
  
Child Maltreatment a (CTQ) Tertiles 
1st  ≤29  131 120 (91.6) 11 (8.4) 1.00  
2nd  30-36 131 112 (85.5) 19 (14.5) 1.85 0.84-4.06 
3rd  ≥37  140 108 (77.1) 32 (22.9) 3.23** 1.55-6.73 
Delinquent Behavior Quartiles 
1st  ≤1  162 147 (90.7) 15 (9.3) 1.0  
2nd  2 or 3 125 107 (85.6) 18 (14.4) 1.65 0.80-3.42 
3rd  4-6 98  83 (84.7) 15 (15.3) 1.77 0.82-3.81 
4th  ≥6  108 91 (84.3) 17 (15.7) 1.83 0.87-3.84 
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Table 3-1 (continued) 
Frequency of outings 
≥ 2 306 272 (89.2) 33 (10.8) 1.0  
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3rd  ≥37  140 108 (77.1) 32 (22.9) 3.23** 1.55-6.73 
Delinquent Behavior Quartiles 
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4th  ≥6  108 91 (84.3) 17 (15.7) 1.83 0.87-3.84 
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Table 3-1 (continued)  
Pubertal Status 
Petersen scale, females, age 14 
≤3  7 5 (71.4) 2 (28.6) 1.00  
≥4 215 179 (83.3) 36 (16.7) 0.50 0.94-2.69 
Petersen scale, males, age 14 
≤3 116 109 (94.0) 7 (6.0) 1.00  
≥4 85 77 (90.6) 8 (9.4) 1.62 0.56-4.65 
Perceived they developed earlier than peers (%) 
No 385 337 (87.5) 48 (12.5) 1.00  
Yes 113 96 (85.0) 17 (15.0) 1.24 0.68-2.26 
Anxiety Quartiles 
1st  ≤2 133 128 (96.2) 5 (3.8) 1.0  
2nd  3-5 124 116 (93.5) 8 (6.5) 1.77 0.56-5.55 
3rd  6-8 121 106 (87.6) 15 (12.4) 3.62* 1.28-10.29 
4th  ≥9  119 82 (68.9) 37 (31.1) 11.55*** 4.36-30.60 
Grade Point Average Quartiles 
1st  ≥3.21  104 92 (88.5) 12 (11.5 1.0  
2nd  2.51-3.20 113 103 (91.2) 10 (8.8) 0.74 0.31-1.80 
3rd 1.91-2.50 140 121 (86.4) 19 (13.6) 1.20 0.56-2.61 
4th  ≤1.90  119 99 (83.2) 20 (16.8) 1.55 0.72-3.35 
General health self-rating 
Excellent  149 136 (91.3) 13 (8.7) 1.00  
Very good 110 101 (91.8) 9 (8.2) 0.93 0.38-2.27 
Good 178  152 (85.4) 26 (14.6) 1.79 0.88-3.62 
Fair/poor  62 45 (72.6) 17 (27.4) 3.95*** 1.78-8.77 
 
a Those children with ‘denial’ subscale scores of >1 were removed from the CTQ analysis so there were only 402 
subjects.  * p<0.05, ** p<0.01, ***p<0.001 
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The rate of MDD was significantly higher among adolescents whose mothers had a 
lifetime history of MDD (including MDD only and comorbid MDD) (OR 1.95, 95% CI 1.15-
3.29) or specifically comorbid MDD (1.78, 1.02-3.11; Table 3-2).  
MDD was not higher among offspring whose mothers had a diagnosis of MDD only, 
GAD, or SUD.  Family income, education, employment status, marital status, presence of an 
adult male in the household, or trait anger also did not differentiate between adolescents with and 
without MDD.   
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 Table  3-2 Maternal characteristics: Unadjusted odds ratios for adolescent MDD 
  
N 
 
Non-MDD 
(%) 
MDD 
 
(%) 
 
Odds 
Ratio 
(OR) 
 
95% CI for 
OR 
Total Cohort                                            499         434 (87.0)         65 (13.0)  
Demographic Factors 
Income quartiles ($/month)      
4th  ≥2800  117 103 (88.0) 14 (12.0) 1.0  
3rd  1700-2800 124 105 (84.7) 19 (15.3) 1.33 0.63-2.80 
2nd  1100-1700 128 115 (89.8) 13 (10.2) 0.83 0.37-1.85 
1st  ≤1100  130 111 (85.4) 19 (14.6) 1.26 0.60-2.64 
Education (years)      
> 12 208 186 (89.4) 22 (10.6) 1.00  
12 243 209 (86.0) 34 (14.0) 1.38 0.78-2.44
< 12 48 39 (81.3) 9 (18.8) 1.95 0.84-4.56 
Employment Status      
Yes 372 325 (87.4) 47 (12.6) 1.00  
No 127 109 (85.8) 18 (14.2) 1.14 0.64-2.05
Marital Status      
Yes 201 179 (89.1) 22 (10.9) 1.00  
No 296 253 (85.5) 43 (14.5) 1.38 0.80-2.39
Male in household      
Yes 254 223 (87.8) 31 (12.2) 1.00  
No 245 211 (86.1) 34 (13.9) 1.16 0.59-1.95
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Table 3-2 (continued) 
Psychological  
     
Trait Anxiety Quartiles      
1st   ≤13  145 126 (86.9) 19 (13.1) 1.00  
2nd   13.1-16 123 116 (94.3) 7 (5.7) 0.40* 0.16-0.99 
3rd   16.1-20.9 105 90 (85.7) 15 (14.3) 1.11 0.53-2.29 
4th   >20.9 123 100 (81.3) 23 (18.7) 1.53 0.79-2.96 
Depression Quartiles      
1st   ≤33 136 123 (90.4) 13 (9.6) 1.00  
2nd   33.1-39 116 106 (91.4) 10 (8.6) 0.89 0.38-2.12 
3rd   39.1-48 134 111 (82.8) 23 (17.2) 1.96 p<0.1 0.95-4.06 
4th   >48 112 93 (83.0) 19 (17.0) 1.93 p<0.1 0.91-4.11 
Trait Anger Quartiles      
1st   ≤13  154 133 (86.4) 21 (13.6) 1.00  
2nd   13.1-15 96 85 (88.5) 11 (11.5) 0.82 0.38-1.79 
3rd   15.1-19 155 136 (87.7) 19 (12.3) 0.89 0.46-1.72 
4th   >19 91 78 (85.7) 13 (14.3) 1.06 0.50-2.23 
Psychiatric 
     
Major Depressive Disorder 
(MDD) 
     
No 320 287 (89.7) 33 (10.3) 1.00  
Yes 175 143 (81.7) 32 (18.3) 1.95* 1.15-3.29 
MDD Only      
No 444 388 (87.4) 56 (12.6) 1.00  
Yes 51 42 (82.4) 9 (17.6) 1.49 0.69-3.22 
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Table 3-2 (continued)  
MDD Comorbid      
No 371 329 (88.7) 42 (11.3) 1.00  
Yes 124 101 (81.5) 23 (18.5) 1.78* 1.02-3.11 
Any DSM-IV disorder other 
than MDD 
     
No 390 338 (86.7) 52 (13.3) 1.00  
Yes 105 92 (87.6) 13 (12.4) 0.92 0.48-1.76 
Generalized Anxiety  
Disorder (GAD) 
     
No 446 388 (87.0) 58 (13.0) 1.00  
Yes 51 44 (86.3) 7 (13.7) 1.06 0.46-2.48 
Any alcohol disorder      
No 397 349 (87.9) 48 (12.1) 1.00  
Yes 96 79 (82.3) 17 (17.7) 1.57 0.86-2.86 
Any marijuana disorder      
No 453 392 (86.5) 61 (13.5) 1.00  
Yes 41 37 (90.2) 4 (9.8) 0.68 0.24-2.02 
Any cocaine disorder      
No 448 388 (86.6) 60 (13.4) 1.00  
Yes 47 42 (89.4) 5 (10.6) 0.77 0.29-2.02 
 
*p<0.05, ** p<0.01, ***p<0.001  
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 3.4.2 Multivariate Analyses 
Variables that were bivariately associated with MDD were entered stepwise into a multivariate 
regression model. Mother’s MDD diagnosis was the only significant predictor among the 
maternal characteristics (adjusted OR=1.80, 1.02-3.18) (Table 3-3).  Adolescent female gender 
(adjusted OR 3.75, 95% CI 1.99-7.08) remained significant. The odds ratio for the highest CTQ 
tertile was significant (3.88, 1.82-8.26) and marginally significant for the second tertile (2.22, 
0.99-4.97, p=0.053). This model had acceptable goodness of fit (Hosmer-Lemeshow χ2=4.31, 
p=0.83).  The significant relation between CTQ and MDD was not mediated by current 
adolescent substance use. 
Table  3-3 Multivariate model 1: Significant covariates of MDD in adolescents 
Variables Entered  Adjusted 
Odds Ratio 
95% C.I. for Odds Ratio p-value 
Female Gender 3.77 2.00-7.12 0.001 
CTQ Score of Adolescents   0.002 
2nd tertile 2.22 0.99-4.97 0.053 
3rd tertile 3.88 1.82-8.26 <0.001 
Maternal MDD  1.80 1.02-3.18 0.044 
 
Number of close friends, alcohol use, cigarette use, and general health of the adolescents were not significant.  
Maternal trait anxiety symptoms, depressive symptoms, and comorbid MDD were not significant. 
 
The interaction between offspring gender and maternal MDD diagnosis was significant 
(p=0.03, Table 3-4 and Figure 3-1).  This interaction was not explained by differences in social 
support, childhood maltreatment, or current substance use.    
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Table  3-4 Multivariate model 2: Significant interaction between gender and maternal MDD  
Variables Entered   Adjusted 
Odds Ratio 
95% C.I. for Odds 
Ratio 
p-value 
Female Gender 2.04 0.92-4.52 0.080 
CTQ Score of Adolescents   0.002 
2nd tertile 2.19 0.97-4.94 0.059 
3rd tertile 3.99 1.86-8.58 <0.001 
Maternal MDD 0.59 0.18-1.96 0.393 
Maternal MDD x Gender 4.58 1.15-18.13 0.030 
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Figure  3-1 Adjusted odds of adolescent MDD: Interaction between gender and maternal MDD 
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3.5 DISCUSSION  
The lifetime prevalence of adolescent MDD was 13%, which parallels the high prevalence of 
maternal MDD (35%) in this cohort.  Although the prevalence of MDD in boys (7.0%) matched 
the rate reported elsewhere (Costello, Mustillo, Erkanli, Keeler, & Angold, 2003), the rate of 
MDD in girls (18.7%) was much higher (11.7%).  Other estimates of lifetime prevalence of 
adolescent MDD are somewhat higher than what we found (15-20%; Birmaher, Ryan, 
Williamson, Brent, Kaufman, Dahl et al., 1996; Kessler, McGonagle, Zhao, Nelson, Hughes, 
Eshleman et al., 1994; Lewinsohn, Hops, Roberts, Seeley, & Andrews, 1993).   
The adjusted odds ratio of MDD among the girls was almost four times that of the boys, 
consistent with findings by Angold and colleagues (1998).  Proposed mechanisms for this gender 
difference include 1) Exposure to increased levels of testosterone and estrogen at puberty, 
especially in the context of social stress, (Angold et al., 1999), 2) Anatomic changes in girls 
reflecting their sexual maturity may be experienced negatively (Stattin & Magnusson, 1990), and 
3) Social changes in school, or in relationships with parents, peers, and romantic/sexual partners 
may increase the number of depression-inducing life events among girls (Cyranowski, Frank, 
Young, & Shear, 2000).   
In the multivariate model, the odds of MDD in the adolescents were almost twice as high 
in offspring of mothers with MDD as in the offspring of women without MDD.  The majority of 
maternal cases of MDD were comorbid with at least one other psychiatric diagnosis, likely 
indicating more severe disease than those women with only a psychiatric diagnosis of MDD.  
Parental psychopathology is one of the strongest factors for depression in offspring (Beardslee et 
al., 1998; Downey & Coyne, 1990; Weissman, Warner, Wickramaratne, Moreau, & Olfson, 
1997).  However, current maternal depressive symptoms and history of other psychiatric 
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disorders were not associated with adolescent MDD.  The association between maternal and 
adolescent MDD may reflect the disorder’s genetic component, environmental effects, or both.   
The interaction of offspring gender and maternal MDD were consistent with other results 
(Fergusson, Horwood, & Lynskey, 1995).  The lack of association between pubertal status and 
depression could have resulted from the narrow range in pubertal status at age 14.   
A history of severe childhood maltreatment increased the adjusted odds of MDD in 
adolescents by almost four times.  Young and colleagues (1997) reported that 35% of adult 
outpatients treated for major depression and anxiety had a history of childhood emotional, 
physical, or sexual abuse.  Chapman et al. (2004) found a dose-response relation between 
adverse childhood events and lifetime depression in adults.  Evidence suggests that childhood 
maltreatment is associated with dysregulation of the HPA axis, which may increase the risk of 
MDD (DeBellis, Chrousos, Dorn, Burke, Helmers, Kling, et al., 1994; Kaufman, Birmaher, 
Perel, Dahl, Moreci, Nelson, et al., 1997). 
Although current adolescent substance use and maternal demographics have been 
associated with adolescent MDD and depressive symptoms (e.g., Costello, Erkanli, Federman, & 
Angold, 1999), we did not find this association.  Unlike other studies, however, we included a 
history of childhood maltreatment and maternal MDD as covariates of adolescent MDD.  
Monthly income, education, and employment status were also not significantly associated with 
adolescent MDD.  The likely reason for this is that there was a narrow SES range in this cohort.   
3.5.1 Limitations 
The mothers in our study were selected on the basis of their prenatal substance use, although 
their use was, in general light to moderate and the sample included women who abstained from 
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use throughout pregnancy.  In addition, this is a low SES cohort.  Thus, they are not 
representative of women in the general population.   
Others have shown that paternal psychiatric diagnoses increase risk of MDD in offspring 
(Klein, Lewinsohn, Rohde, Seeley, & Olino, 2005).  A limitation of our study is a lack of data on 
the fathers.   
The high correlation between self-reported anxiety and MDD obviated the use of both in 
the regression model.  However, although anxiety and depressive disorders share symptoms, a 
diagnosis of MDD is distinguished from GAD by whether the patient has primarily a depressed 
or anxious mood.  Thus, we are confident that we have established significant predictors and 
covariates of major depressive disorder in adolescents.   
The diagnostic data used here are lifetime diagnoses.  Our present study did not focus on 
whether the mother’s first MDD episode preceded the child’s.  This limits our ability to make 
statements about causality.    
3.5.2 Clinical Implications 
Female gender, a history of childhood maltreatment, and a maternal history of MDD each 
increased the odds of adolescent MDD.  The likelihood of having an MDD diagnosis is further 
increased among female adolescents whose mothers have a history of MDD.  Our findings 
suggest that routine psychiatric assessment of maltreated children and daughters of women with 
MDD would improve the early identification and treatment of adolescent depression.  
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4.0  MANUSCRIPT 3:  THE RELATION BETWEEN MATERNAL ANXIETY 
DURING PREGNANCY AND LEVEL OF DEPRESSIVE SYMPTOMS IN LATE 
CHILDHOOD AND ADOLESCENCE OF OFFSPRING 
4.1 SUMMARY 
For this study, we hypothesized that after controlling for confounding variables, prenatal 
maternal anxiety will predict depressive symptom level in children from ages 10 to 16 years.  
Women (n=829) of low socioeconomic status, recruited from a hospital-based prenatal clinic to 
study prenatal alcohol and marijuana use, were assessed for trait anxiety using the State Trait 
Personality Inventory (STPI; Spielberger, 1979) during their fourth gestational month.  At the 10, 
14, and 16-year follow-ups, trait anxiety (STPI) and depressive symptoms were measured in 
women (Center for Epidemiologic Studies-Depression Scale; CES-D; Radloff, 1977) and their 
offspring (Children’s Depression Inventory; CDI; Kovacs, 1981, 1992).  Repeated measures 
mixed linear models were used to test the hypothesis.  Covariates included prenatal and current 
demographic, social, and maternal substance use, child gender, and follow-up year.   
Results were as follows: 1) Maternal anxiety and depressive symptoms were highly 
correlated across the follow-up assessments. 2) Boys’ levels of self-reported depressive 
symptoms were highest at 10 years and decreased significantly at the 14 and 16-year 
assessments; girls’ level of symptoms did not change over time.  3) Prenatal maternal anxiety 
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significantly predicted depressive symptoms in offspring from age 10 to 16 years. 4) Prenatal 
maternal anxiety remained a significant predictor of depressive symptoms in offspring, 
controlling for current maternal depressive symptoms. 5) The relation between prenatal maternal 
anxiety and child depressive symptoms was marginally significant (p=0.09) after adding child 
gender and prenatal maternal educational status. 6) There was a significant interaction between 
gender and follow-up year in predicting depressive symptom level in offspring from age 10 to 16 
years. 
 Maternal anxiety during pregnancy has long term effects on the level of depressive 
symptoms in offspring during late childhood and adolescence.  To reduce the risk of children 
developing depressive symptoms, healthcare providers should aim prevention efforts at 
improving psychological health and reducing anxiety during or prior to pregnancy. 
4.2 INTRODUCTION  
There has been renewed interest in recent years in the effects of gestational stress and anxiety on 
the offspring (Van den Bergh, Mulder, Mennes, & Glover, 2005).  Maternal anxiety during 
pregnancy predicts negative emotionality in infants at 10 and 28 weeks of age (Van den Bergh, 
1990).  Another study showed that prenatal maternal stress has a significant effect on the fetus in 
middle childhood, evidenced by increased behavioral and emotional problems in 6 ½ year-old 
offspring (O'Connor, Heron, Golding, & Glover, 2003).   
Fetal programming results when an insult to the fetus produces long-lasting or life-long 
effects.  Two areas of the developing brain are likely affected by prenatal exposure to anxiety: 
The prefrontal cortex, which is responsible for organizing and integrating brain signals involved 
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in behavioral/emotional regulation in children and adults (Grossman, Chruchill, McKinney, 
Kodish, Otte, & Greenough, 2003; Ladd, Huot, Thrivikraman, Nemeroff, Meaney, & Plotsky, 
2000), and the hypothalamic-pituitary-adrenal (HPA) axis, which has a role in the etiology of 
major depressive disorder (MDD; Arborelius, Owens, Plotsky, & Nemeroff, 1999; Holsboer, 
2000).   
Elevated anxiety levels in pregnant women result in elevated glucocorticoids (specifically 
cortisol in humans) that could affect the developing fetal HPA-axis.  Glucocorticoids are central 
to the physiological response to stress in mammals, including humans.  The HPA-axis is 
particularly susceptible to perinatal programming by glucocorticoids, at least in animal models 
(Barker, 1998; Schneider & Moore, 2000; Welberg, Seckl, & Holmes, 2001) and dysregulation 
of the HPA-axis prenatally could lead to the development of depression or depressive symptoms.  
There is recent evidence in humans indicating that prenatal anxiety predicts HPA-axis 
dysregulation in childhood, as measured by higher salivary cortisol levels in 10-year-old children 
(O’Connor, Ben-Shlomo, Heron, Golding, Adams, & Glover, 2005).   
Direct effects of maternal cortisol are unlikely during the normal physiologic conditions 
of pregnancy, as the placenta contains the enzyme 11β-hydroxysteroid dehydrogenase Type 2 
(11β-HSD2), which rapidly inactivates maternal cortisol before it enters fetal circulation 
(Lindsay, Linday, Edwards, & Seckl, 1996).  However, the effects of maternal stress and anxiety 
on the functioning of this enzyme are unknown.  It is possible that maternal cortisol that is 
elevated beyond normal pregnancy levels, could overwhelm the placental enzyme’s ability to 
inactivate the cortisol, allowing the hormone to reach the fetus and modify HPA-axis 
development.  An alternate mechanism involves fetal cortisol.  Maternal cortisol positively 
correlates with fetal cortisol (Gitau, Cameron, & Fisk, 1998), and there is positive feedback 
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between fetal cortisol and placental Corticotropin Releasing Hormone (CRH), which supports 
the maternal stress response (Laatikainen, 1991; Lederman, 1996).  Maternal stress/anxiety may 
also affect the fetal brain through decreased uterine blood flow (Teixeira, Fisk, & Glover, 1999) 
and fetal hypoxemia (Myers, 1977).    
 It is our aim to determine whether prenatal maternal anxiety contributes to level of 
depressive symptoms in the offspring during late childhood and adolescence.  We will examine 
depressive symptoms beginning at 10 years, a time when depressive symptoms are likely to first 
appear (Birmaher, Ryan, Williamson, Brent, Kaufman, Dahl et al., 1996).  To evaluate these 
effects through adolescence, we will follow the children’s depressive symptoms to age 16 years.  
We hypothesize that prenatal maternal anxiety will predict depressive symptoms in the offspring, 
after controlling for current maternal depressive symptoms, and other confounding variables.   
4.3 METHODS 
4.3.1 Study Design 
The Maternal Health Practices and Child Development (MHPCD) Project is a longitudinal study, 
begun in 1982, that examines the long-term effects of prenatal substance use on the physical and 
mental health of offspring.  The women were selected from a hospital-based prenatal clinic and 
were of lower socioeconomic status.   In total, 1360 women were recruited during their fourth 
prenatal month.  From these women, two cohorts were selected for studies of prenatal alcohol 
and marijuana use.  The selection criteria for the alcohol cohort were: women who drank alcohol 
at the rate of three or more drinks per week in the first trimester of pregnancy, and the next 
  104
woman who drank less than that amount or who abstained.  For the marijuana cohort the criteria 
were: women who used marijuana as often as twice a month, and the next woman who used less 
or abstained.  Women could be in either or both cohorts.  The present analysis combined these 
two cohorts, for a total of 829 women at the first assessment (fourth gestational month).  This 
study uses data from the fourth prenatal month and the 10, 14, and 16-year follow-up 
assessments.  Analyses included children and their biological mothers who had at least one 
follow-up assessment at 10 (n=588), 14 (n=527), or 16 years (n=509).  Other caregiver/child 
dyads were excluded from the analyses so that we could control for the association between 
prenatal anxiety and current maternal depressive symptoms. The Institutional Review Boards of 
Magee-Womens Hospital and of the University of Pittsburgh approved the study and all women 
gave signed, informed consent for themselves and on behalf of their children.  
4.3.2 Measurements 
4.3.2.1 Demographic Status 
Race and age were self-designated by the women at the first assessment.  Marital status, monthly 
family income, employment status, and education were ascertained at all time points.  Whether 
or not the women lived with a male in the household was assessed at all follow-up time points.  
The following variables were dichotomized:  race (African American/Caucasian), marital status 
(married/unmarried), and employment status (employed or in school/ unemployed and not in 
school).  Age, monthly income, and educational level at the prenatal assessment were 
categorized to reduce skewness.  Using quintiles, we created five approximately equal groups for 
maternal age and monthly income variables.  The number of years of maternal schooling at the 
prenatal assessment (<12 years, 12 years, or >12 years) was used as the measure of education. 
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4.3.2.2 Maternal Social Support and Life Events  
Social support was a composite of questions from the first assessment: 1) how frequently she 
talks to friends, 2) how frequently she talks to relatives, 3) if she has someone to turn to in times 
of need, and 4) how satisfied she is with the help from friends and relatives.  Stressful life events 
were assessed at delivery by asking the women to report events that occurred during pregnancy.  
4.3.2.3 Prenatal Substance Use 
At each prenatal assessment, women reported their use during the previous trimester of alcohol, 
cigarettes, marijuana, cocaine, and other illicit drugs.  The women were asked about the quantity 
and frequency of the usual, maximum, and minimum use of alcohol and marijuana.  Women 
were also asked about the quantity and frequency of tobacco, cocaine, and other illicit drugs.  
The average daily number of alcoholic drinks, marijuana joints, and cigarettes used were 
calculated and treated as continuous variables.  Alcohol and marijuana use variables for all time 
points were log-transformed to reduce skewness of the distributions.  Because the use of cocaine 
and other illicit drugs was low, illicit drug use was dichotomized (any/none). 
4.3.2.4 Maternal and Child Psychological Measures 
Maternal 
Trait anxiety is a predisposition to experience anxiety in a stressful situation. State anxiety is a 
transient emotional response characterized by unpleasant feelings of tension and apprehensive 
thoughts (Spielberger, 1966).  The two measures are highly correlated (Albrecht & Rankin, 
1989).  In this study, trait anxiety (score range: 10-40) was assessed in women using the State-
Trait Personality Inventory (STPI; Spielberger, 1979).  Ten items from the State-Trait Anxiety 
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Inventory (STAI; Spielberger, 1983) were selected for this measure based on the following 
criteria:  high corrected item-total correlations, relatively low item-scale correlations with the 
trait anger subscale of the STPI, and high factor loadings.  This instrument was used because it 
was shorter.  The time frame of the STPI was modified for our study, and women reported on 
how they had felt over the last trimester.  The trait anxiety measure at the fourth prenatal month 
was selected as the measure for these analyses for the following reasons: 1) the correlation was 
very high between the assessments of the first, second, and third trimester (r=0.65 to 0.75); 2) 
there were more missing subjects at the seventh gestational month assessment (n=69); 3) as we 
were interested in anxiety reports during pregnancy, it was inappropriate to use the assessment of 
anxiety soon after delivery. 
Depressive symptoms in women were assessed during pregnancy and at follow-up time 
points using the Center for Epidemiologic Studies-Depression Scale (CES-D; range: 0-60; 
Radloff, 1977), a 20-item questionnaire developed to measure symptoms in general and 
psychiatric populations.  The women reported how they felt about each of the items over the 
previous trimester.  Subsequent assessments asked the women to report on how they felt during 
the past two weeks. 
The STPI and the CES-D were administered to the women at each phase.  Our analyses 
use the trait anxiety assessment at the fourth prenatal month and the CES-D assessments from 
the 10, 14, and 16-year follow-ups.  Current depressive symptoms in the women refer to those 
measured at the same assessment as their children’s depressive symptoms. 
Higher scores on both of the scales indicate more symptoms.  The sample mean of a 
particular question was used to replace missing data if no more than 10% of the responses to 
questions were missing (i.e., a maximum of 1 item for the anxiety scale and a maximum of 2 
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items for the depression scale). Thus, for the prenatal assessment, 1 missing trait anxiety item 
was imputed for 20 women.  For the 10, 14, and 16-year follow ups, 1 missing CES-D item was 
imputed for 12, 7, and 18 women, respectively; 2 missing CES-D items were imputed for 0, 3, 
and 4 women, respectively.    
Child 
The Children’s Depression Inventory (CDI; Kovacs, 1981, 1992) was used to assess self-
reported depressive symptoms in the offspring at ages 10, 14, and 16 years.  The CDI consists of 
27 items which assess negative mood, anhedonia, ineffectiveness, negative self-esteem, and 
interpersonal problems in the past 2 weeks.  Each item is assessed with statements corresponding 
to a score ranging from 0 to 2, with 0 = absence of symptom, 1 = mild symptom, and 2 = definite 
symptom.  These scores correspond to the child’s selection of the statement that best describes 
himself/herself:  I am sad once in a while (0); I am sad much of the time (1); I am sad all the time 
(2). The total raw score means are reported in these analyses (range: 0-44).  In order to reduce 
the missing data, up to 4 items on the CDI were filled in using regression imputation.  Thus, 1 
item was imputed at the 10, 14, and 16-year assessments for 30, 16, and 8 subjects, respectively.  
Two items were imputed for 5, 5, and 3 subjects, respectively. Three items were imputed for 1, 
1, and 13 subjects, respectively.  At the 16-year assessment, 4 items were imputed for one 
subject only. 
4.3.3 Data Analysis 
The CDI score was log-transformed to reduce positive skewness and all estimates reported are 
for the transformed outcome.  Data were included in the analyses for all follow-up points at 
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which the child and biological mother were assessed.  Potentially confounding variables were 
identified using bivariate analyses (Pearson correlations, t-tests, and Analysis of Variance) of 
prenatal maternal demographic, social, and substance use variables with prenatal maternal 
anxiety and CDI scores at 10, 14, and 16.  To test group differences of CDI scores by gender and 
follow-up year, t-tests and Analysis of Variance (ANOVA) were used, respectively.   
Repeated measures mixed linear models were used to determine whether prenatal 
maternal anxiety symptoms predicted depressive symptoms in offspring across ages 10, 14, and 
16 years.  This approach allowed us to include the CDI data from all subjects assessed at each 
time point.  The covariates were added to the models based on the following: 1) well-established 
literature on their correlation with child depression level; and/or 2) from bivariate analyses at 
each follow-up.  Models were created by adding one fixed effect variable at a time.  Prenatal 
maternal anxiety (the main predictor of interest) and year of follow-up (10, 14, 16) were tested 
first.  Next, current maternal depressive symptoms were considered.  The following confounding 
variables were finally tested stepwise:  child gender, race, first trimester maternal cigarette use, 
and maternal education level at the first assessment.  First trimester substance use was chosen a 
priori for entry into the model because it was measured at the same time as prenatal anxiety.  
After the significant main effects were identified, all possible statistical interactions between 
variables were tested.  Participant-specific intercepts were modeled as random effects.  
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4.4  RESULTS 
4.4.1 Sample Description 
Table 4-1 summarizes the demographic and substance use characteristics of women at the fourth 
gestational month, and at the 16-year follow-up.  The sample is racially balanced between 
Caucasians and African Americans.  The sample is of low socioeconomic status and the majority 
of the women at both the prenatal and the 16-year phases were single and high-school educated.  
At the prenatal assessment, the majority of the women was unemployed and not in school, 
whereas 16 years later, the majority was employed or in school.  Substance use by the women at 
the first trimester was as follows: 0.39 marijuana joints/day; 8.3 cigarettes/day; 0.62 alcoholic 
drinks/day. (Table 4-1)  Mean use of all substances was lower at later trimesters, with the 
exception of cigarettes.  
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Table  4-1 Demographic characteristics at prenatal and 16-year phases 
Maternal Variable  Prenatal (n=763) a   16-year Follow-up (n=509) 
Demographics: 
  
Age (years) 23 (4) 40 (4) 
African American  (%) 51 54 
Median family income (monthly) 300-399 1700 
Employed (%) 27 74 
Single (%) 64 60 
Education (years completed)  12 (1.4) 12 (2.0) 
      Male in household(%) (not available) 50 
   
Substance Use  First Trimester  
Marijuana joints/day 0.39 (range, 0-9) 0.09 (range, 0-6) 
Abstainers (%) 60.3  
Cigarettes/day 8.3 (range, 0-50) 8.1 (range, 0-60) 
Abstainers (%) 49.1  
Alcoholic drinks/day 0.62 (range, 0-20) 0.86 (range, 0-26) 
Abstainers (%) 36.9  
Illicit drugs (%) 11 5 
Cocaine (%) 4 3 
   
  
a Means with standard deviations in parentheses are presented, unless otherwise noted. 
 
The birth cohort was generally healthy with means: birth weight, 3.20 kg; birth length, 
49.3 cm; head circumference, 34.1 cm; and gestational age, 39.7 weeks. Eleven percent of the 
offspring were low birth weight (<2500 g); 9% were preterm (<37 weeks gestation); and 10% 
were small for gestational age.  The cohort of children at the three follow-up assessments was 
balanced with respect to gender (49-50% male) and race (46-47% Caucasian).  
4.4.2 Maternal and Child Psychological Variables 
The women in our study took neither antidepressants nor anxiolytics during pregnancy.  The 
mean anxiety scores for the women at the prenatal phase and at 10, 14, and 16 years were 17.8, 
  111
  112
16.7, 16.6, and 17.1, respectively; mean depression scores were 20.8, 18.2, 18.6, and 20.3, 
respectively (Table 4-2).   
Mean CDI scores for offspring over the three follow-up assessments were 7.4, 7.0, and 
6.3, for 10, 14, and 16 years, respectively (Table 4-2).  These scores differed over time 
(F(1603,2)=2.47, p=0.085).  Table 4-2 provides the correlations between psychological variables 
for mothers and their children.  Prenatal maternal anxiety symptoms were significantly correlated 
(p<0.01) with maternal anxiety and depressive symptom measures at each of the three follow-up 
points (r=0.37, for anxiety, at all points; r=0.34, 0.31, and 0.28, for depression, at 10, 14, and 16 
years, respectively.  Prenatal maternal anxiety symptoms were significantly associated with child 
depressive symptoms at ages 10 and 16 years (r=0.12, p<0.01 and r=0.11, p<0.05, respectively), 
whereas prenatal maternal depressive symptoms were significantly correlated with child 
depressive symptoms at only age 16 (r=0.14, p<0.01; Table 4-2). 
 Maternal  Anxiety Symptoms 
(STPI) 
Maternal Depressive Symptoms 
(CES-D) 
Child Depressive 
Symptoms  (CDI) 
Follow-up Period Prenatal 10-yr 14-yr 16-yr Prenatal 10-yr 14-yr 16-yr 10-yr 14-yr 16-yr 
 
Descriptive Statistics 
           
n 761 588 527 505 757 587 526 507 580 523 503 
Mean Score 17.8 16.7 16.6 17.1 20.8 18.2 18.6 20.3 7.4 7.0 6.3 
Standard Deviation 4.7 4.7 9.9 5.3 8.7 9.5 9.9 10.7 6.6 6.4 5.8 
 
Pearson Correlations 
           
Maternal Anxiety 
Symptoms 
           
Prenatal - 0.37** 0.37** 0.37** 0.71** 0.34** 0.31** 0.28** 0.12** 0.08 0.11* 
10-yr  - 0.53** 0.55** 0.31** 0.77** 0.46** 0.47** 0.11** 0.04 0.11* 
14-yr   - 0.64** 0.32** 0.45** 0.74** 0.55** 0.06 0.07 0.16** 
16-yr    - 0.34** 0.52** 0.55** 0.78** 0.09 0.07 0.21** 
Maternal Depressive 
Symptoms 
           
Prenatal     - 0.36** 0.38** 0.39** 0.07 0.06 0.14** 
10-yr      - 0.55** 0.57** 0.13** 0.07 0.09* 
14-yr       - 0.64** 0.09* 0.11* 0.18** 
16-yr        - 0.09* 0.09* 0.20** 
Child Depressive 
Symptoms 
           
10-yr         - 0.30** 0.31** 
14-yr          - 0.61** 
16-yr           - 
            
 
 Note: Only biological mothers were included in the analyses. 
  
Table  4-2 Psychological descriptive statistics and correlations for mothers and their children 
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* p<0.05  ** p<0.01 
 
4.4.3 Bivariate Analyses of Prenatal Covariates 
Significant covariates of prenatal anxiety included: African American race, lower family 
income, lower education, less social support, more cigarette and alcohol use during the 
first and second trimesters, and more cigarette use during the third trimester.  Marijuana, 
cocaine and other illicit drug use were not associated with prenatal anxiety.  Of these 
significant correlates of prenatal anxiety, the confounding variables (i.e., those 
significantly associated with both prenatal anxiety and CDI score at least at one follow-
up assessment) included: race, education level, and cigarette use at all trimesters (Table 
4-3).  Female gender was associated with higher CDI score at the 14 and 16-year follow-
up assessments (t(484)=3.78, p<0.001, and t(501)=2.53, p=0.012).  Unexpectedly, female 
gender was associated with higher PMA (t(588)=2.4, p=0.015).  Thus, not only was 
gender a covariate of child depressive symptoms, but it was also a confounding variable 
in the relation between PMA and child depressive symptoms. 
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 Table  4-3 Associations of maternal variables during pregnancy with prenatal maternal 
anxiety and Children’s Depression Inventory scores at follow-up phases 
Maternal Variable  Associations  Between Maternal Characteristics and Offspring Psychological Scores 
 Prenatal 
Anxiety 
(n=763) 
Age 10 CDI 
(n=588) 
Age 14 CDI 
(n=527) 
Age 16 CDI 
(n=509) 
Demographic/social 
variables  during 
pregnancy: 
    
Age a 0.93 2.10 0.77 1.07 
African American b 2.4* 2.59** - 2.19* -1.33 
Lower family income a 2.93* 1.70 0.17 0.78 
Unemployed b 0.88 1.49 1.44 1.05 
Single b 1.92m 1.14 -1.54 -0.70 
Lower Education a 3.43* 2.72 m 4.44* 3.34* 
     Life events a 2.03 0.80 0.19 0.77 
      Social support a 13.9** 0.97 0.63 0.52 
     
Substance Use for 1st 
trimester: 
    
Marijuana joints/day c 0.037 0.138** -0.006 0.026 
Cigarettes/day c 0.089* 0.048 0.121** 0.066 
Alcoholic drinks/day c 0.105** 0.031 0.067 0.042 
Illicit drug use b -1.46 -0.36 -0.24 0.30 
Cocaine use b 0.37 -0.22 0.34 0.18 
     
 
  a F statistic reported.   b t-statistic reported. c Pearson correlation coefficient reported.   
* p<0.05  ** p<0.01 m Marginally significant (p<0.1)
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4.4.4 Mixed Linear Models 
4.4.4.1 Main Effects 
PMA measured at the fourth prenatal month significantly predicted (p=0.002) depressive 
symptoms in offspring from 10 to 16 years, adjusting only for the follow-up year (Table 4-4).  
After adjusting for follow-up year and current maternal depressive symptoms, prenatal maternal 
anxiety symptoms remained a significant predictor (p=0.033) of depressive symptoms in 
offspring.   After adding gender and maternal education to the model, PMA was marginally 
significant (p=0.09).  Table 4-4 
Table  4-4 Prenatal maternal anxiety predicts depressive symptoms in children:  Adjusted main 
effects models 
Step 1 β p-value 95% CI of Estimate 
Prenatal maternal anxiety    0.0085 0.002 0.0032, 0.0137 
Follow-up year -0.0089 0.005 -0.0151, -0.0028 
 
Step 2 β p-value 95% CI of Estimate 
Prenatal maternal anxiety 0.0059 0.033 0.0004, 0.0112 
Follow-up year -0.0102 0.001 -0.0164, -0.0040 
Current maternal depressive symptoms 0.0043 <0.001 0.0022, 0.0063 
 
Step 3 β p-value 95% CI of Estimate 
Prenatal maternal anxiety  0.0048 0.093 -0.0008, 0.0105 
Follow-up year -0.0106 0.001 -0.0171, -0.0042 
Current maternal depressive symptoms 0.0043 <0.001 0.0022, 0.0064 
Maternal education -0.054 0.013 -0.0959, -0.011 
Offspring gender (male) -0.0521 0.050 -0.1041, -0.0001 
    
  
4.4.4.2 Statistical Interactions 
We tested all combinations of the variables that had significant main effects for statistical 
interactions. There was a significant interaction between follow-up age and gender (p<0.001; 
  116
Table 4-5; Figure 4-1), and a marginally significant interaction between gender and maternal 
depressive symptoms (p=0.055).   
 At the 10-year follow-up, the girls’ mean CDI was not significantly different from that of 
the boys.  However, at the 14 and 16-year follow-ups, girls reported significantly higher levels of 
depressive symptoms than boys (t(484)=3.78 and t(501)=2.53, respectively). (Figure 4-1) The 
boys’ mean CDI score decreased over time (7.8, 5.8, 5.4, F(728, 2)=8.75, p<0.001, for 10, 14, 
and 16 years, respectively).  The differences between ages 10 and 14 years, and 10 and 16 years 
were significant.  Girls’ mean CDI scores did not differ over the three time points (7.1, 8.3, 7.2, 
F(760,2)=2.85, p=0.058). In the final model, prenatal maternal anxiety was a marginally 
significant (p=0.08) predictor of depressive symptoms in children from 10 to 16 years (Table 4-
5). 
Table  4-5 Prenatal maternal anxiety predicts depressive symptoms in children: Final model 
including interactions 
 β p-value 95% CI of Estimate 
Prenatal maternal anxiety  0.0050 0.080 -0.0005, -0.0106 
Follow-up year -0.0240 <0.001 -0.0330, -0.0151 
Current maternal depressive symptoms 0.0043 <0.001 0.0022, 0.0064 
Offspring gender (male) 0.3230 0.001 0.1403, 0.5057 
Maternal education -0.0534 0.013 -0.0955, -0.0112 
Follow-up year * gender (male) -0.0269 <0.001 -0.0395, -0.0143  
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Figure  4-1 Mean depressive symptoms during late childhood and adolescence: Interaction between 
gender and follow-up year 
Significant differences in mean CDI score between males and females are indicated:  
* p<0.01  ** p<0.001 
4.5 DISCUSSION  
Maternal anxiety during pregnancy is a predictor of the level of depressive symptoms in late 
childhood and adolescence.  This finding is consistent with the fetal programming hypothesis.   
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Our analyses confirmed that current maternal depressive symptoms are highly related to 
offspring depressive symptoms, as has been reported previously (Da Costa, Larouche, Drista, & 
Brender, 2000; Demyttenaere, Lenaerts, Nijs, & Van Assche, 1995;  Beardslee, Versage, & 
Gladstone, 1998; Downey & Coyne, 1990; Gelfand & Teti, 1990).  However, prenatal maternal 
anxiety remained a significant predictor of offspring depressive symptoms after controlling for 
current maternal depressive symptoms.  Thus, the association between PMA and child 
depression cannot be simply explained by the high correlation between anxiety and depression.  
After controlling for maternal education and child gender, the relation between prenatal maternal 
anxiety and level of depressive symptoms in the offspring became marginally significant 
(p<0.10).   
In an earlier manuscript we reported a significant interaction between gender and 
maternal major depressive disorder (MDD) in predicting MDD in the adolescent offspring 
(Hosseini, Day, Brooks, Wroble Biglan, Gorin, & Larkby, unpublished manuscript).  In the 
present analysis of depressive symptoms, we have also found that girls of depressed mothers are 
at higher risk than would be expected from the independent effects of being female and having a 
mother with depressive symptoms.  This disproportionately increased risk in girls of depressed 
mothers could be due, in part, to their increased sensitivity to family discord, a correlate of 
maternal depression (Davies & Windle, 1997; Fergusson, Horwood, & Lynskey, 1995). 
Our finding of a significant interaction between follow-up year and gender is in accord 
with the literature that levels of depressive symptoms in boys and girls are similar prior to 
adolescence, and diverge beyond age 13 years (Twenge & Nolen-Hoeksema, 2002).  Although 
many studies have reported that this divergence is due to an increase in symptoms among girls 
(e.g., Hankin & Abramson, 1999; Nolen-Hoeksema & Girgus, 1994), in our cohort the 
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divergence is due to a significant decrease in depressive symptoms in the boys at the 14 and 16-
year assessments.  This difference in findings may be partially attributable to differences in study 
design.  In a meta-analysis of 310 samples of children ages 8-16, Twenge & Nolen-Hoeksema 
(2002) found that testing effects due to repeated administration of the CDI in longitudinal studies 
resulted in lower CDI scores over time, as compared with results from cross-sectional studies 
using the CDI.  They estimated that the magnitude of this longitudinal testing effect in the 
negative direction was equivalent to previously reported increases in girls’ CDI scores during 
adolescence.  Thus, any real increase in level of depressive symptoms in the girls would be offset 
by the testing effect, such that their level of depressive symptoms would appear constant during 
late childhood and adolescence.  This is a potential explanation of why the levels of depressive 
symptoms in the girls appeared to be constant and those of males appeared to decrease in our 
longitudinal analyses.   
There are several limitations to this report. We did not explore the effects of the timing of 
anxiety during pregnancy and, because anxiety and depressive symptoms in the mothers were 
very highly correlated, it was not possible to control for each separately. Furthermore, because 
our sample consists of lower socioeconomic status women, some of whom were substance users 
during pregnancy, our results may not be generalized to the population at large.  Nevertheless, 
our study had several advantages.  We had a large, racially-balanced cohort and a dataset that 
provided a wealth of variables.  The study design allowed us to investigate the relation between a 
prenatal variable and a longitudinal outcome in the children several years later.  The retention 
rate was high over the sixteen years (approximately 70%).   Finally, a major advantage of our 
study over some others is our reliance upon child self-report of depressive symptoms, rather than 
parental report. 
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The mean CDI scores for the children were within the normal range (Kovacs, 1981; 
1992).  However, the fact that there is a significant effect of PMA on the level of depressive 
symptoms, even below the range of clinical significance, is important.  Moderate and non-
diagnostic levels of depressive symptoms in childhood can negatively affect academic and social 
performance (Nolen-Hoeksema, Girgus, & Seligman, 1992; Susman, Dorn, & Chrousos, 1991).  
Non-clinical levels of depressive symptoms and the resultant psychosocial impairments persist 
into adulthood (Rohde, Lewinsohn, & Seeley, 1991; Nolen-Hoeksema et al., 1992) and are risk 
factors for subsequent Major Depressive and Substance Use Disorders (Angst & Merikangas, 
1997; Fergusson, Horwood, Ridder, & Beautrais, 2005; Lewinsohn, Solomon, Seeley, & Zeiss, 
2000).  Thus, an increased rate of depressive symptoms may have important implications for 
long-term prognosis. 
In conclusion, trait anxiety in pregnant women predicted depressive symptom levels in 
their children from 10 to 16 years of age.  This relation remained significant after controlling for 
current maternal depressive symptoms. Prevention efforts aimed at improving the psychological 
well-being in expectant mothers may be important for reducing the risk of subsequent mental 
health problems in their offspring.   Maternal education and female gender are also risk factors 
that should be considered when assessing a child’s risk for developing depression.    
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5.0  SUMMARY/CONCLUSIONS 
5.1 OVERVIEW OF MANUSCRIPTS 1, 2, AND 3 
Initially, the overarching hypothesis of this dissertation was that exposure to prenatal maternal 
anxiety (PMA) would predict major depressive disorder (MDD) in 16-year-old adolescent 
offspring.  In order to explore this hypothesis, it was crucial to establish the potential 
confounders of this relation.  In a first step, Manuscript 1, entitled “Trait anxiety in pregnant 
women predicts offspring birth outcomes,” we established the significant covariates of PMA, and 
examined prediction of adverse birth outcomes by PMA.  In regression models, trait anxiety 
measured at the 7th gestational month and shortly after delivery predicted lower birthweight and 
shorter birth length, controlling for confounds. Anxiety reported shortly after delivery was 
associated with shortened gestational age, controlling for confounds.  Further, Manuscript 1 
described PMA severity and duration as they related to birth outcomes.  At the 4th and 7th 
gestational month assessments, the relation of birthweight and birth length to maternal trait 
anxiety was only significant for severe anxiety.  Women whose anxiety reached severe levels for 
at least two of the three assessments were significantly more likely to deliver offspring of lower 
birthweight and shorter birth length than those women who reported severe anxiety at none or 
one of the assessments.  Additionally, offspring of women who experienced severe anxiety 
during three assessments had shorter mean gestational age compared to offspring of women who 
did not report severe anxiety at any assessment.  Thus, we concluded in Manuscript 1 that 
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women who report chronic, severe trait anxiety are at the highest risk of having shorter 
gestations and delivering smaller babies. These findings confirmed that there were at least short 
term effects of PMA on children’s physical outcomes; this encouraged us to explore the potential 
lasting effects of PMA on development of psychiatric/psychological outcomes, namely major 
depression and depressive symptoms in the offspring. 
Next, in Manuscript 2, entitled “Covariates of major depressive disorder in mid-
adolescence,” the significant covariates of MDD in adolescent offspring were determined 
bivariately and the strongest predictors and correlates were established in a multivariate logistic 
regression model.  The lifetime prevalence of MDD among the 16-year-old adolescents was 13 
%.  Female gender, history of severe childhood maltreatment, and maternal diagnosis of MDD 
independently increased the odds of MDD in adolescents.  There was a significant interaction 
between offspring gender and maternal MDD.  We concluded that these risk factors, especially 
girls whose mothers had MDD, should prompt early screening and intervention in children.  
These results pointed to the potential confounders which we would need to consider for 
Manuscript 3. 
Preliminary analyses for Manuscript 3 revealed that there was no significant bivariate 
association between PMA at any of the three prenatal assessments and MDD in the 16-year-old 
offspring, nor were there any significant bivariate associations between MDD and any of the 
covariates of PMA.  Thus, the outcome of interest was changed.  The outcomes explored in 
Manuscript 3 were depressive symptoms over the 10-, 14-, and 16-year assessments.  The paper 
was entitled “The relation between maternal anxiety during pregnancy and level of depressive 
symptoms in late childhood and adolescence of offspring.”  There were two advantages of using 
this new outcome: 1) The full range of depressive symptoms was explored, and 2) All three 
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assessments during late childhood and adolescence were used.  Drawing on the richness of our 
longitudinal data allowed us a fuller picture of the longitudinal course of depression and 
depressive symptoms in the children than would a diagnosis of MDD, which simply measured 
lifetime prevalence.  The theory supporting this new overarching hypothesis essentially remained 
the same:  fetal programming due to PMA exposure makes the offspring more liable to 
developing depressive symptoms.   
Based on Manuscripts 1 and 2 which determined the significant covariates of PMA and 
MDD, respectively, we determined which variables needed to be considered as potential 
confounders in exploring the relation between PMA and depressive symptoms in Manuscript 3.  
We additionally confirmed that history of childhood maltreatment, and the other bivariately 
significant covariates established in Manuscript 2, were not confounders of the relation.  
However, based upon the findings in Manuscript 2 of a significant interaction between gender 
and maternal depression (i.e., MDD) and upon the fact that maternal depression was a 
confounder of the relation, we controlled for both gender and current maternal depressive 
symptoms in Manuscript 3.  Furthermore, several correlates of PMA in Manuscript 1 were also 
correlates of depressive symptoms in children (including race, maternal education, and prenatal 
cigarette and alcohol use). 
In Manuscript 3 we found the following: 1) Maternal anxiety and level of depressive 
symptoms were highly correlated across the follow-up assessments. 2) Boys’ levels of self-
reported depressive symptoms significantly decreased at the 14 and 16-year assessments, as 
compared with the 10-year assessment; girls’ level of symptoms did not significantly change 
over time.  3) Prenatal maternal anxiety significantly predicted depressive symptoms in offspring 
from age 10 to 16 years, controlling for the follow-up year. 4) After controlling for current 
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maternal depressive symptoms, prenatal maternal anxiety remained an independent significant 
predictor of depressive symptoms in offspring. 5) Additionally controlling for child gender and 
prenatal maternal educational status rendered the relation between prenatal maternal anxiety and 
child depressive symptoms marginally significant (p=0.09). 6) There was a significant statistical 
interaction between gender and follow-up year in predicting depressive symptom level in 
offspring from age 10 to 16 years.  We concluded that maternal anxiety during pregnancy has 
lasting effects on the level of depression of offspring into late childhood and adolescence.  Thus, 
clinicians should aim prevention efforts at improving psychological health and reducing anxiety 
in women during the prenatal period, and continue depression screening in women throughout 
their offspring’s childhood and adolescence.   
5.2 FETAL PROGRAMMING BY PRENATAL MATERNAL ANXIETY 
Traditionally, familial risk of depression has been thought to be primarily conferred through 
either genetic inheritance, or through environmental effects of exposure to post-natal maternal 
depression, as the child is growing up. Our results indicate that an additional mechanism, fetal 
programming by maternal anxiety, plays an important role in development of depressive 
symptoms.   
Formation of the hypothalamus, pituitary, and adrenal glands occurs throughout 
gestation, with fetal HPA activity beginning at midgestation (Gitau, Fisk, Teixeira, Cameron, & 
Glover, 2001).  Thus, it may be susceptible to the ill effects of elevated stress and anxiety levels 
in pregnant women.  The potential mechanisms for modification of the fetal HPA-axis were 
discussed in greater detail in the introductory section and in Manuscript 3.  Additionally, the 
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prefrontal cortex has been implicated as one of the potentially susceptible parts of the fetal brain 
because it is responsible for organizing and integrating brain signals involved in 
behavioral/emotional regulation in children and adults (Grossman, Churchill, McKinney, 
Kodish, Otte, & Greenough, 2003; Ladd, Huot, Thrivikraman, Nemeroff, Meaney, & Plotsky, 
2000).   
5.3 TIMING OF EXPOSURE TO PRENATAL MATERNAL ANXIETY 
Because the literature has already established that prenatal anxiety/stress negatively impacts birth 
outcome, we did not want to simply duplicate others’ findings.  Rather, we were interested in 
using our measure of PMA at the two assessments during pregnancy and the one at delivery to 
determine which assessment(s) were best in predicting birth outcome, and whether at each of 
these assessments, trait anxiety was a stronger predictor than either depression or trait anger in 
the pregnant women.  Furthermore, we used all three assessments of maternal anxiety in order to 
determine the effects of duration of anxiety.  Despite our findings in Manuscript 1 that anxiety 
measured at the 2nd and 3rd assessments were significant predictors of birth outcome, we selected 
the 1st assessment of PMA as our predictor of depressive symptoms in children.  Our justification 
for doing so was discussed in Manuscript 3. 
 A consequence of our choice to only use the 1st assessment of PMA is that we are limited 
in our ability to make conclusions about gestational periods for which the fetus is more 
susceptible to the modifying effects of PMA.  Even if we were to treat our measure of trait 
anxiety as one of state anxiety, as we did for Manuscript 1, then we would be limited by the 1 ½ 
month range of the first assessment. Although many women were first assessed during their 4th 
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gestational month (n=516), many were first assessed at their 4 ½ month (n=245), and a 
substantial number came in as late as their 5 ½ month of pregnancy (n=76).  Thus, this 
assessment generally represented mid-gestation. 
   
5.4 LOW BIRTH WEIGHT AND ADVERSE BIRTH OUTCOMES AS MARKERS OF 
DYSREGULATED HPA AXIS 
There is evidence that birth weight impacts on child and adult health (e. g., Clark, Hindmarsh, 
Sheill, Law, Honour, & Barker, 1996; Phillips & Jones, 2006).   Adjusting for sex and current 
weight, both high and low birth weight babies have elevated urinary cortisol in childhood, 
presumably reflecting lasting effects of an adverse fetal environment (Clark et al., 1996).  
Although low birth weight, preterm delivery, and other pregnancy complications have been 
shown by some authors to predict MDD in adolescents and adults (e. g., Jablensky, Morgan, 
Zubrick, Bower, & Yellachich, 2005; Patton, Coffey, Carlin, Olsson, & Morley, 2004), we found 
no such association in our cohort.   
We hypothesized a significant relation between adverse birth outcomes (including lower 
birth weight, low birth weight, shortened gestational length, preterm delivery, and small for 
gestational age) and depression in the offspring.  We found significant associations between 
child depressive symptoms at age 10 and the following birth outcomes: small size for gestational 
age; low birth weight.  Low birth weight significantly mediated the relation between prenatal 
maternal anxiety and age 10 depressive symptoms in children (results not included in 
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Manuscripts).  However, none of the birth outcomes was associated with either MDD diagnosis, 
or depressive symptoms at ages 14 or 16 years.   
A potential explanation for our inability to detect a relation between birth outcome and 
longitudinal depressive symptoms, is that our cohort of adolescents generally had healthy birth 
outcomes (mean birth weight= 3.19 kg, SD=0.58; 11% were low birthweight (< 2.5 kg); mean 
gestational age=39.7 weeks, SD=2.2; 9 % were preterm (< 37 gestation weeks); 10% were small 
for gestational age).  
5.5 CHILDHOOD MALTREATMENT  
In Manuscript 2, we report our findings that history of childhood maltreatment significantly 
predicts a lifetime diagnosis of MDD in 16-year-old adolescents.  Although our childhood 
maltreatment findings are consistent with the literature, their interpretation is limited by several 
factors.  First of all, our assessment did not include information about the timing or duration of 
childhood maltreatment.  Furthermore, in order to understand better the mechanisms of 
experiencing childhood maltreatment, a next step would be to explore the specific categories of 
maltreatment (i.e., emotional neglect and abuse; physical neglect and abuse; and sexual abuse).  
Finally, because we do not have information on who the abuser/neglectful caretaker was, we 
cannot assume that the mechanism is poor parenting. 
The proposed biological mechanism for the overarching hypothesis of this dissertation 
may encompass the effects of childhood maltreatment as well.  As the HPA axis is susceptible to 
modification by stresses even after birth, it has been suggested that HPA-axis dysregulation may 
be the etiological link between childhood maltreatment and subsequent mood and anxiety 
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disorders (Kendall-Tacket, 2000; Shea, Walsh, MacMillan, & Steiner, 2004; Teicher, Andersen, 
Polcari, Anderson, Navalta, & Kim, 2003). 
5.6 PMA ? DEPRESSION RELATION 
The vast majority of cases of MDD in our cohort had an onset at age 11 years or later (mean 
age=13.8 years, SD=2.5, range: “earlier than I can remember” to 17 years).  Because we would 
expect depressive symptoms to be elevated beginning around 10 years of age in some children, it 
was appropriate that we began measuring depressive symptoms at this age.  The dual finding of a 
non-significant association of PMA with MDD and a significant association between PMA and 
depressive symptoms in children 10 to 16 years old may be explained by the effects of PMA 
being chronic and generally sub-threshold for clinical depression.  This is not surprising 
considering the dimensional nature of the STPI measure of trait anxiety as including sub-clinical 
anxiety.  Although the effects of PMA in our cohort are not strong enough to predict MDD, this 
does not render their effects on child depressive symptoms trivial.   
5.7 CLINICAL IMPORTANCE OF SUB-THRESHOLD DEPRESSIVE SYMPTOMS 
Many groups (e.g., Angst & Merikangas, 1997; Fergusson, Horwood, Ridder, & Beautrais, 2005; 
Lewinsohn, Solomon, Seeley, & Zeiss, 2000) have lent support to the idea that major depression, 
as defined by DSM-IV, is a categorical diagnosis imposed on a continuum of depressive 
symptoms of varying severity and duration.  During the past few years, these researchers have 
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been particularly interested in examining “sub-threshold depression.” In the study by Lewinsohn 
et al. (2000), the authors found that increasing depressive symptoms (i.e., higher CES-D score) 
predicted worse psychosocial dysfunction and higher incidence of both, major depressive and 
substance use disorders.  Thus, Lewinsohn’s group concluded that even non-diagnosable levels 
of depression are risk factors for poor prognosis.  Fergusson et al. (2005) longitudinally followed 
a community sample of adolescents in order to determine the association between extent of 
depressive symptoms (no symptoms, sub-threshold, major depression) in late adolescence and 
outcomes at age 25.  After adjusting for confounding variables, the adolescents’ extent of 
depression significantly predicted major depression, number of depressive symptoms, suicidal 
ideations and treatment for anxiety-related disorders.  This study essentially found that those 
subjects with sub-threshold depression had a similar prognosis as those with MDD.  This lends 
support to the idea that MDD patients are not a discrete group which differs from those not 
meeting DSM-IV criteria.  
Angst & Merikangas (1997) found that the prevalence of threshold and sub-threshold 
categories of depression were similar and that many subjects with depression met the criteria for 
multiple depressive subtypes (including major depression, recurrent brief depression, minor 
depression, and dysthymia) over a 15-year period.  Furthermore, they found that sub-threshold 
depression is associated with a large increase in the risk of the subsequent development of MDD 
over time.  Their findings suggest that brief recurrence of even low-level depression may have 
important implications for long-term prognosis.  In light of these authors’ findings, our results 
for depressive symptoms from ages 10 to 16 years have clinical relevance. 
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5.8 PUBLIC HEALTH IMPLICATIONS 
Several key factors for preventing depression in children and adolescents are indicated.  Our 
findings that anxiety in pregnant women affected birth outcomes and depressive symptoms in 
offspring point to the need for reducing anxiety in these women. Studies are called for which 
assess whether prenatal care that addresses the psychological well-being of pregnant women 
would result in improved birth outcomes.  Anxious women should be identified early in or even 
prior to pregnancy and targeted for anxiety reduction.  Furthermore, in multivariate models, 
lower maternal education significantly predicted both shortened birth length and higher 
depressive symptoms in offspring; this is a relatively easily identifiable indicator of risk which 
could be used more extensively by clinicians. 
Prevention of abuse and neglect during a child’s development is also a key factor in 
reducing their risk of MDD, not to mention the various other improvements in a child’s life 
which would result from such prevention.  Once childhood maltreatment is detected, however, 
early intervention targeted at these children may lower rates of MDD in adolescence.   
Finally, ensuring the psychological health of mothers throughout their children’s 
development is expected to greatly decrease the risk of depression.  Olson and colleagues (2006) 
recently implemented a brief depression screening of mothers at well-child visits.  They found 
that such a program was feasible, not time-consuming, and that it added significant value in 
detecting potentially depressed women. Many of the mothers were open to discussion about the 
impact of their mental health on their child, and furthermore, some mothers received referrals 
from the pediatricians. Thus, we would recommend maternal screening for depression by 
pediatricians beginning in early childhood, so that the mother may be referred for the appropriate 
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care.  Finally, it has been shown that interventions such as group cognitive therapy are effective 
in preventing depression in adolescent offspring of depressed parents (Clarke et al., 2002). 
 
5.9 FUTURE DIRECTIONS 
Based our current findings, future research could be taken in several directions.  Importantly, our 
study controlled for the effects of maternal depression concurrent with those measurements in 
the children at ages 10, 14, and 16 years.  However, there may be additional effects of post-natal 
depression in early infancy which predispose the children to behavioral/emotional problems 
(O’Connor, Heron, & Glover, 2002).  Thus, future studies could control for such early post-natal 
depression in mothers.  A second direction is that our cohort of children could be followed into 
adulthood to see if the effects of prenatal maternal anxiety on depressive symptoms last into 
adulthood, and whether a relation with MDD emerges.   
Third, new studies could incorporate measures of maternal state anxiety at several points 
throughout pregnancy.  As it is known that brain development continues throughout gestation, 
and that many developmental processes occur at precise times (Nowakowski & Hayes, 2002), 
identifying periods when the fetus is especially sensitive to the harmful effects of maternal 
anxiety is beneficial:   1) It has implications for prevention in highly anxious pregnant women, 
and 2) It may also hold the potential of revealing which developmental processes of early brain 
development were disturbed. Finally, as in another recent study, measuring cortisol in the 
children (and even later in adulthood) could provide insight into whether HPA-axis is 
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dysregulated in prenatal anxiety-exposed children (O’Connor, Ben-Shlomo, Heron, Golding, 
Adams, & Glover, 2005).   
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